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Macrophages (MФ) and mast cells are important cell types in the context of tissue 
remodeling and regeneration. Mast cells participate in the early stages of wound healing 
and modulate the acute inflammatory responses to biomaterials. Mast cells can secrete a 
myriad of different cytokines by the process of degranulation; the process of regulated 
secretion in which preformed contents stored in their granules are rapidly released by 
exocytosis. Some of these cytokines such as IL-4, IL-13 and TNF-α can modulate the MФ 
xvii 
 
phenotype. Macrophages (MΦ) are innate immune cells, crucial for tissue homeostasis, 
presentation of foreign and self-antigens following infection/injury, pathogen clearance, 
inflammation resolution, angiogenesis, and wound healing. MΦ display plasticity and can 
acquire pro-inflammatory (M1) or angiogenic/wound healing (M2) phenotypes depending 
upon the environmental stimuli. The phenotypic profile of MФ as M1 or M2 following 
exposure to the biomaterial can dictate the downstream processes of tissue remodeling 
and angiogenesis. An analysis of  how these two cell types interact with electrospun 
biomaterials and how different properties of an electrospun biomaterial impacts the MΦ 
phenotype is the focus of this thesis. 
Mast cells synthesize several potent angiogenic factors and can also stimulate 
fibroblasts, endothelial cells and macrophages. An understanding of how they participate in 
wound healing and angiogenesis is important to further our knowledge about in situ 
vascular prosthetic regeneration. The adhesion, proliferation and cytokine secretion of 
bone marrow derived murine mast cells (BMMC) on electrospun polydioxanone (PDO), 
polycaprolactone (PCL) and silk scaffolds, as well as tissue culture plastic (TCP) has been 
investigated in the presence or absence of IL-3, SCF, IgE and IgE with a crosslinking 
antigen, dinitrophenol-conjugated albumin (DNP). It was previously believed that only 
activated BMMCs exhibit adhesion and cytokine secretion. However, this study shows non-
activated BMMC adhesion to electrospun scaffolds. Silk scaffold was not found to be 
conducive for mast cell adhesion and cytokine secretion. Activation by IgE and DNP 
significantly enhanced mast cell adhesion, proliferation, migration and secretion of TNF-α, 
MIP-1α and IL-13. This indicates that mast cells might play a role in MФ polarization 
xviii 
 
(M1/M2), biomaterial integration into the host tissue, regeneration, and possibly 
angiogenesis. 
In the next study, bone marrow derived murine macrophages (BMMΦs, 106 cells) 
were seeded on TCP (24 well plate) and PDO scaffolds (15 mm discs) electrospun from 
varying polymer concentrations (60, 100, and 140 mg/ml). Scaffold evaluation showed that 
large polymer concentrations led to larger fiber diameters, which in turn led to larger pore-
sizes and porosity but a smaller surface area to volume ratio. After 24 hrs of culture, the 
cell lysates were analyzed for Arginase (Arg1) and inducible nitric oxide synthase (iNOS) 
expression by western blot and cell culture supernatants were analyzed for Nitric oxide 
(NO2-), Tumor Necrosis Factor – alpha (TNF-α), Interleukin-6 (IL-6), Vascular Endothelial 
Growth Factor (VEGF), Transforming Growth Factor – beta1 (TGF-β1) and basic fibroblast 
growth factor (bFGF) levels. The results indicated a correlation between Arg1 expression 
and increasing fiber/pore-size, indicating that the larger fiber/pore-sizes polarize towards 
a M2 phenotype. Also, the expression of iNOS was downregulated on the larger fiber/pore-
size. The levels of NO2- were significantly higher on the lower fiber/pore-sizes indicating an 
M1 phenotype. The levels of VEGF, TGF-β1 and bFGF increased with increasing fiber/pore-
sizes. The results showed higher Arg1 expression in M2s on the 60 mg/ml scaffold created 
by the air-flow impedance method compared to the 60 mg/ml scaffold created on the solid 
mandrel created by traditional electrospinning. The Arg1 expression was reduced on the 
compressed 140 mg/ml PDO scaffold compared to the normal 140 mg/ml scaffold. This 
result indicates that pore-size might be playing a greater role compared to fiber diameter 
in BMMФ phenotype modulation.  
 
xix 
 
In order to assess the angiogenic potential of BMMΦs cultured on PDO scaffolds, a 
3D angiogenesis bead assay was performed using conditioned media from the BMMΦ:PDO 
interaction. The results of the 3D angiogenesis bead assay showed that the conditioned 
media from BMMΦs of M0 and M2 phenotypes cultured on the 140 mg/ml PDO scaffold 
induced larger sprouting and higher percentage density of sprouts when compared to the 
60 mg/ml PDO scaffold and TCP.  
To investigate the signaling mechanism involved in this phenotypic switch, BMMΦs 
were isolated from the bone marrow of MyD88 knockout (KO) mice (Jackson Laboratories) 
and cultured on PDO (60 and 140 mg/ml) scaffolds (106 /disc) and TCP for 24 hrs and their 
Arg1 and iNOS expression was analyzed by western blot. The expression of Arg1 and iNOS 
was severely impaired on the BMMΦs from MyD88-/- mice cultured on the 140 mg/ml 
scaffold when compared to the 60 mg/ml PDO scaffold and TCP. This result indicates that 
scaffolds with different fiber/pore-sizes signal differently. 
A subcutaneous mouse model (described in Chapter 6) was used to evaluate the 
angiogenic and regenerative potential of PDO scaffolds in vivo. The DIVAA assay showed 
statistically higher FITC-dextran signal intensity for the 140 mg/ml scaffold compared to 
the 60 mg/ml scaffold indicating greater angiogenic response in the 140 mg/ml tube.  
However, problems of high background were observed in this assay with the use of 
electrospun PDO.  The observed high background was probably due to the formation of 
complexes between dextran and adsorbed plasma proteins on the surface of the PDO. More 
studies are needed to optimize this assay for use with biomaterials such as PDO. H&E 
staining of the harvested PDO tubes (60 mg/ml and 140 mg/ml) was also performed. The 
xx 
 
cross-sections of these tubes showed greater cell recruitment and infiltration into the 
fibrous structures of the 140 mg/ml tube compared to the 60 mg/ml tube.  This result 
corroborates the in vitro result of BMMФ infiltrating deeper into the structures of the 140 
mg/ml scaffold compared to the 60 mg/ml scaffold. The scaffolds were also analyzed by 
immunostaining for iNOS (indicative of M1 phenotype of MФs). The results showed 
statistically higher ratios of iNOS positive:negative areas on the 60 mg/ml scaffold 
compared to the 140 mg/ml scaffold. Overall, these studies indicate that 140 mg/ml 
scaffold supports greater cell recruitment and cell infiltration in vivo but a smaller ratio of 
iNOS positive:negative areas compared to the 60 mg/ml scaffold, which supports a 
predominately M1 MФ phenotype. 
  The studies indicate that varying properties of PDO can alter both the phenotype 
and function of BMMΦs in vitro and in vivo. We have also shown that the 140 mg/ml 
scaffold signal BMMΦs through MyD88-dependent mechanisms. A complete 
understanding of the way materials signal would allow us to control or modulate 
undesirable immune reactions to biomaterials in vivo. These studies would also help 
engineer biomaterials that promote angiogenesis and regeneration in vivo.
 1 
 
 
 
 
 
 
 
 
Chapter I: Introduction 
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I.1 Host Response to Biomaterials 
The host response to tissue injury or implanted biomaterials occurs in four main 
stages: hemostasis, inflammation, proliferation, and remodeling (Figure 1). In the very 
early process of implantation, injury to the tissue and vasculature activates platelets. The 
activation of platelets results in the release of clotting factors that initiate hemostasis. A 
provisional matrix forms on the surface of the biomaterials consisting of fibrin and 
entrapped erythrocytes. This provisional matrix provides structural, biochemical and 
cellular components to the process of wound healing. It serves as a substrate for cell 
migration and a medium for cell signaling. In addition to the activation of clotting factors, 
platelets also release several cytokines and chemokines such as platelet derived growth 
factor (PDGF), Transforming growth factor beta (TGF-β1), C-X-C ligand 4 (CXCL4) and 
inteleukin-1beta (IL-1β). These factors contribute to tissue repair by recruiting several 
different cell types including neutrophils, macrophages and fibroblasts. Neutrophils are the 
first inflammatory cell type to arrive at the wound site. They phagocytose and destroy 
foreign material, bacteria and dead cell debris. Mast cells also mediate acute inflammatory 
responses to implanted biomaterials by releasing granules containing enzymes, histamine, 
and other factors such as IL-4 and IL-13 that modulate the inflammatory response. 
Neutrophils are quickly replaced by monocytes as the predominant cell type. Three reasons 
account for this phenomenon: (1) Neutrophils have a short half-life and disintegrate and 
disappear after 24-48h. (2) The chemotactic factors for neutrophil migration are activated 
early in the inflammatory response. (3) After emigration from the vasculature, monocytes 
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differentiate into Macrophages (MФ) and these cells have a much longer life span 
(~months). MФ begin to dominate the cell population by day 48-72 h post-injury.  
MФ continue the process debridement and disinfection by removing apoptotic 
neutrophils and bacteria. In response to microbial products such as lipopolysaccharide 
(LPS) and cytokines such as interferon–gamma (IFN-γ), MФ acquire an M1 phenotype. 
These MФ destroy pathogens by phagocytosis and by production of reactive nitrogen and 
oxygen species, including nitric oxide (NO), peroxynitrite (ONOO-), hydrogen peroxide 
(H2O2) and superoxide (O2). M1s also produce a myriad of enzymes such as matrix 
metalloproteases (MMPs), collagenase, elastase and hyaluronidase and are crucial in 
matrix destruction and tissue reorganization at the injured tissues. This also allows them to 
quickly migrate through the injured tissues to clear pathogens and debris. Prolonged 
activation of M1s can lead to tissue injury. Therefore, this phenotype must be quickly 
abolished to make way for a tissue regenerative M2 phenotype. The size, shape, dimensions 
and chemical and physical properties of the biomaterial may be responsible for variations 
in the intensity and time duration of the inflammatory and wound healing processes. M2 
macrophages are induced by a variety of signals such as IL-4, IL-13 and IL-10. M2s produce 
arginase, which allows them to convert arginine to ornithine, a precursor of polyamines 
and collagen, thereby contributing to the production of extracellular matrix (ECM). M2s 
also produce large amounts of chitinase and chitinase-like molecules including YM1 and 
YM2. These chitinase –like molecules have carbohydrate and matrix binding activity and 
play a role in matrix reorganization and wound healing. M2 macrophages also release 
several growth factors such as VEGF, TGF-β1 and bFGF which play a key role in the next 
stage of wound healing; the proliferative phase. 
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The proliferative phase of wound healing involves cellular proliferation, 
angiogenesis, new ECM deposition and formation of granulation tissue. Granulation tissue 
derives its name from the pink, soft granular appearance on the surface of healing wounds. 
Its characteristic histological features include the proliferation of new blood vessels and 
fibroblasts. The process of formation of new blood vessels from pre-existing vasculature is 
angiogenesis (or neovascularization). Angiogenesis involves proliferation, maturation and 
organization of endothelial cells into capillary tubes. The development of granulation tissue 
also involves proliferating fibroblasts which actively synthesize collagen and 
proteoglycans. In the early stages of granulation tissue development, proteoglycans 
predominate; however at later stages collagen type I predominates and forms the fibrous 
capsule. In the granulation tissue, some fibroblasts may take up the features of smooth 
muscle cells and these cells are termed myofibroblasts.  These cells are believed to be 
responsible for wound contraction seen during the development of the granulation tissue. 
Fibrous materials generally have a surface response composed of multinucleated giant 
cells. These cells are formed by the fusion of MФ in an attempt to phagocytose the material 
and are called foreign body giant cells. These cells may persist on the tissue-biomaterial 
interface for the lifetime of the biomaterial. Adherent human MФ/foreign body giant cells 
(FBGCs) on biomaterials produce MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 
and TIMP-2 in vitro. The adherent MФ/FBGCs on a biomaterial surface can modulate ECM 
remodeling/fibrosis and therefore affect biomaterial performance [1-4]. Typically 
biomaterials heal with a fibrous encapsulation surrounding the biomaterial with its 
interfacial foreign body reaction. This encapsulation isolates the biomaterial from the 
surrounding tissue and prevents its integration with the native tissue. In normal wound 
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healing, after the deposition of new ECM, the remodeling phase of wound healing begins. 
This phase is characterized by MMP and TIMP-mediated degradation and remodeling of the 
newly deposited ECM, usually resulting in scar tissue formation/maturation.  
 
Figure 1 The stages of wound healing [5]. 
 
I.2 Macrophage Polarization in Wound Healing 
Macrophages belong to the mononuclear phagocyte system. This system comprises 
the bone marrow monoblasts, pro-monocytes, peripheral blood monocytes and tissue 
macrophages. They share a common progenitor cell with granulocytes in the bone marrow. 
This common progenitor is called the colony-forming unit, granulocyte-macrophage (CFU-
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GM) because of its ability to give rise to colonies of monocytes and neutrophils in a semi-
solid marrow cultures. When monocytes enter the blood stream and migrate into tissues, 
they undergo final differentiation to tissue macrophages. Macrophages are present 
ubiquitously in all tissues and display great structural and functional heterogeneity as 
histiocytes, alveolar macrophages (lungs), Kupffer cells (liver), osteoclasts (bone), 
peritoneal macrophages (peritoneum), synovia type A cells (synovium), or microglia 
(central nervous system). Macrophages are set into different functional states by a process 
known as activation. Activation of macrophages entails increased phagocytic or 
microbicidal activities and alteration of their chemotactic response and secretory activities. 
Activation is a complex process involving different stimuli. Macrophages increase 
performance of some functions and down regulate others. Macrophages can secrete a 
repertoire of proteases and growth factors  such as bFGF, GM-CSF,  transforming growth 
factor- alpha (TGF-α), TGF-β, insulin-like growth factor-I (IGF-I), platelet-derived growth 
factor (PDGF), VEGF, and other cytokines such as IL-1, IL-6, IL-8 and TNF- α. They also 
secrete neurotransmitter such as substance P, lipid mediators such as prostaglandins, 
interferons, and anti-angiogenic substances such as thrombospondin 1 [6].  
The specialization and activation of these cells are mainly influenced by local stimuli 
[7, 8]. Classically activated macrophages (M1) are produced during cell mediated 
immunity. They can arise in response to IFN-γ, which can be produced during an adaptive 
immune response by T helper 1 (TH1) cells or CD8+ T cells or during an innate immune 
response by natural killer (NK) cells. Alternatively activated macrophages (or wound 
healing macrophages, M2) arise in response to IL-4, which can be produced during an 
adaptive immune response by TH2 cells or during an innate response by granulocytes. IFN-
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γ can prime macrophages to secrete pro-inflammatory cytokines, produce increased 
amounts of superoxide anions and oxygen and nitrogen radicals (e.g. iNOS) to increase 
killing ability. M1 macrophages produce high levels of IL-12 and modest levels of IL-10. 
They also secrete IL-1, IL-6 and IL-23. M2 macrophages produce low levels of both IL-12 
and IL-10. These macrophages fail to present antigen to T cells, produce minimal amounts 
of pro-inflammatory cytokines and are less efficient than M1 macrophages at producing 
toxic oxygen and nitrogen radicals. The M2 macrophages also have increased arginase 
activity that allows them to convert arginine to ornithine, a precursor to of polyamines and 
collagen, thereby contributing to the production of extracellular matrix. M2 macrophages 
also produce large amounts of chitinase like molecules like YM1 and YM2. These molecules 
lack chitin degrading ability, but they have carbohydrate and matrix binding ability. They 
also express the antigen resistin like molecule-α (RELMα; also known as FIZZ1) [8-12]. The 
activation states of MФ are hypothetical ends of a spectrum. The actual MФ phenotype is 
viewed as a continuum of functional states.  
Recently M2s were further divided into M2a, M2b and M2c based on their different 
roles in tissue remodeling (Figure 2). M2a phenotype arises in response to IL-4 and IL-13 
and these MФ are associated with Th2 responses. The M2b phenotype is induced by 
immune complexes as well as agonists of TLRs or IL-1 receptors and these MФ secrete high 
amounts of IL-10 but reduced IL-12. M2c phenotype is induced by IL-10 or glucocorticoids. 
They produce elevated levels of IL-10 and TGF-β1 and are associated with immune 
suppression and remodeling [3, 13]. In contrast, INF-γ or TNF-α primed MФs are grouped 
as M1s. These MФs have decreased phagocytic capability and (FcγR)II expression. M1s 
secrete pro-inflammatory cytokines, such as TNF-α, IL-1, IL-6, IL-12, and IL-23, possess 
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anti-proliferative functions and induce Th1 responses. In addition, M1s are also crucial in 
matrix destruction and tissue reorganization at injured tissues via the production of a 
variety of enzymes such as MMPs, collagenase, elastase and hyaluronidase. This allows M1s 
to quickly migrate through injured tissues to clear pathogens and debris [3]. Mosser et al. 
suggested a spectrum of MФ phenotypes and characterized MФ populations based on three 
fundamental homeostatic activities, including host defense, wound healing, and immune 
regulation. MФ are grouped into three primary phenotypes: classically activated MФ for 
microbicidal activity, wound-healing MФ for tissue repair, and regulatory MФ for anti-
inflammatory activity [12]. 
MФ phenotypes exhibit plasticity, meaning that a classically activated M1 can switch 
to an alternatively activated M2 (Figure 3). Prolonged activation of M1s can lead to tissue 
injury. Therefore, after disinfecting and debriding the wound site, the M1s must switch 
over to M2s at later stages to facilitate proper tissue remodeling. 
It has been established from previous studies that the fate of a tissue engineered 
implant depends upon the kind of MФ response it elicits [14]. Biological responses to 
implanted materials involve neutrophil mediated detoxification, followed by MФ activity to 
phagocytize debris and co-ordinate remodeling events. Several different cell types 
including natural killer (NK) cells, basophils, mast cells and innate lymphoid cells can 
polarize macrophages to either a M1 or M2 phenotype (Figure 3). Mast cell derived 
Interleukin-4 (IL-4) and IL-13 were found to be inductors of MФ fusion while TNF-α was 
responsible for biomaterial adherent MФ apoptosis [15]. Mast cell derived IL-4 and IL-13 
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can also lead to alternatively activated MФ (M2 phenotype) which play a role in matrix 
remodeling, angiogenesis and elimination of parasites [13]. 
It has been demonstrated that mast cell derived TNF-α is a crucial component of 
host defense against bacterial infection and is involved in recruitment of leukocytes by 
establishing cytokine networks [17, 18]. MФ may also be responsible for the development 
of mast cells, since removal of MФs greatly reduced the mast cell development in vitro [19].  
In a recent study skin biopsies from human patients were obtained and gene 
expression was analyzed on early (Day 1-2) and late stages (Day 4-8) of cutaneous wound 
healing (Figure 4). It was observed that the early stage included a mix of M1 and M2 
markers (11 M1 genes and 7 M2 genes) whereas the late stage expressed predominately 
M2 markers (1 M1 gene and 9 M2 genes) [20].  
It has been shown by Greisler et al. [21-25], Valentin et al. [26], Roh et al. [27], and 
Brown et al. [28] that macrophages play a key role in the success and potential failure of 
any vascular prosthetic. Tissue regeneration begins with phagocytosis of debris and ECM 
remodeling and reorganization through enzymes released by the macrophage which 
include proteinase, collagenase, elastase and hyaluronidase [29]. 
The second step involves cell recruitment, migration, proliferation and ECM 
formation via the spectrum of cytokines produced by the macrophage. The third and final 
step of tissue regeneration is angiogenesis, a process by which new capillaries are 
generated from a pre-existing vascular system. 
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Figure 2 An illustration of macrophage phenotypes, their inducers, phenotype and 
functions as depicted by Kou et al. [3]. 
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Figure 3 Macrophage polarization in wound healing [16]. 
 
 
Figure 4 Gene Expression Profiling of Macrophages in cutaneous wound healing [17]. 
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Angiogenesis is fundamental to wound healing, reproduction and embryonic 
development [18]. It results from stimulation of endothelial cells, which causes them to 
proliferate and migrate towards the source of pro-angiogenic molecules. On reaching a 
certain appropriate density, junctions between endothelial cells are formed, components of 
ECM are produced and a new basal membrane is formed [19]. The endothelial cells then 
progress to form a hollow tube. All steps in this transformation are induced by the myriad 
of growth factors derived from the macrophage. The outstanding role of macrophages in 
angiogenesis can be attributed to their much longer half-life as compared to granulocytes 
and platelets and secretion of myriad growth factors for initiation, maintenance and 
termination of the angiogenic process. Also, macrophages are resident in all tissues in 
greater numbers than other blood borne cells and the distinct subtypes can always be 
recruited from the blood stream. They have heterogeneous functionality and can be 
activated from an inactive non-angiogenic stage to an angiogenic stage [6].  
MФs bind to foreign surfaces such as biomaterials via integrin-mediated 
interactions with the adsorbed protein layer on the material surfaces. MФs express 
integrins with three different types of β chains: β1, β2, and β3. MФs have three β1 
integrins, including α4/β1 that binds fibronectin and VCAM-1, α5/β1 that binds fibronectin 
and α6/β1 that binds laminin. There are four β2 integrins, including αD/β2 and αL/β2 that 
bind ICAMs, αM/β2 that binds ICAMs and various other ligands such as fibrinogen, Factor 
X, elastase, and complement fragment C3bi, and αX/β2 that binds C3bi, fibrinogen, and LPS. 
MФs have only one β3 integrin, αV/β3, that binds vitronectin, entactin, and ECM proteins 
containing RGD- and KGAGDV- sequences. These interactions between MФ integrins and 
the adsorbed cell-adhesive proteins provide intracellular signals that are crucial in 
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regulating the functions of MФs, including cytoskeletal remodeling, gene transcription, 
spreading, motility, proliferation, apoptosis, survival, and fusion [1, 3, 20]. 
MФ response to biomaterials is also dependent on their size. It has been shown that 
when foreign materials are < 10 µm, MФ can effectively phagocytose them. The process of 
phagocytosis leads to the formation of membrane bound phagosomes in the cytoplasm. The 
phagosomes fuse with endosomes and lysosomes to form phagolysosomes, which contain 
proteolytic and microbicidal substances to kill, digest and degrade the internalized 
particles. On encountering larger foreign materials (10-100 µm) that cannot be engulfed by 
a single MФ, multinucleated MФs or FBGCs are formed by the fusion of multiple MФs. 
These FBGCs then phagocytose and digest the foreign materials. When FBGCs encounter 
bulk materials that even they cannot effectively engulf, they undergo a process called 
“frustrated phagocytosis”. In this process MФs release an array of substances such as 
cytokines, reactive oxygen species and proteolytic enzymes in an attempt to degrade the 
implanted materials [1]. 
I.3 Signaling Mechanisms Involved In Macrophage Polarization 
Within the array of MФ surface molecules, the toll-like receptors (TLRs), specialized 
membrane proteins that recognize pathogen-specific antigenic patterns, are the likely 
candidates for mediating biomaterial- MФ interactions (key MФ activators).  TLRs may be 
found on the cell surface (TLR-1, 2, 4, 5 and 6) or intracellular (TLR-3, 7, 9).  Upon ligand 
exposure, TLRs couple to signaling adaptors to induce two major downstream signaling 
pathways, nuclear factor kappa B (NFκB) and interferon response factor (IRF). Myeloid 
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differentiation factor-88 (MyD88) is an essential adapter protein involved in TLR signaling 
pathways (except TLR-3) leading to the activation of NFκB.  
Different TLRs use different combinations of adaptor proteins to determine 
downstream signaling. TLR4 is the only known TLR which utilizes all these adaptor 
proteins [21]. The majority of TLR’s signal through MyD88, which couples the TLR to 
downstream signaling kinases, eventually leading to the activation of NFκB by 
translocation from the cytoplasm to the nucleus. However, MyD88 independent signaling 
pathways do exist for TLR3 and TLR4.  TLR4 possesses two options for signal transduction, 
either to signal through MyD88 or through TIR domain containing adapter inducing 
interferon-beta (TRIF), while TLR3 can signal only through TRIF [22].  
MyD88 contains a death domain (DD), which can recruit other DD-containing 
molecules through homotypic interactions. Upon LPS stimulation, MyD88 recruits and 
activates IL-1 receptor associated kinase 4 (IRAK-4). IRAK-4 is responsible for the 
subsequent recruitment, activation and degradation of IRAK-1. Another adaptor protein 
TRAF6 (TNF receptor associated factor 6), is critical for the MyD88 dependent pathway 
downstream of IRAK4 and IRAK1. TRAF 6 activates TAK1 (transforming growth factor-β-
activated kinase 1). TAK1 then activates downstream IKK (inhibitor of κ light chain gene 
enhancer in B cells (IκB) kinase) and MAPK (mitogen-activated protein kinase) pathways. 
IKK complex phosphorylates IκB proteins. This phosphorylation leads to the degradation of 
IκB proteins and subsequent translocation of the transcription factor NFκB, which controls 
the expression of proinflammatory cytokines, in addition to other immune related genes. 
The MyD88-dependent pathway can also activate p38 and c-Jun N-terminal kinase (JNK), 
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leading to AP-1 activation followed by transcription of genes involved in regulation of cell 
proliferation, morphogenesis, apoptosis, and differentiation. 
TLR4 can also signal via a MyD88-independent pathway to stimulate the production 
of the antiviral protein interferon (IFN)-β. TLR4 can recruit another TIR-domain-
containing adaptor called TRIF. Like MyD88, activated TRIF can bind to TRAF-6 to activate 
NFκB. Unlike MyD88, TRIF can also bind to kinases called IκKε and TBK1. These kinases 
activate transcription factors called IRFs (interferon regulatory factors) that are involved in 
stimulating IFN-β transcription. Thus, the adaptor TRIF enables TLR4 signaling to induce 
production of IFN-β in addition to activation of NFκB [23]. 
It is known that wound healing is impaired in MyD88 deficient mice, characterized 
by delayed wound closure and granulation tissue formation and a decreased density of new 
blood vessels [24].  In a recent study, it was demonstrated that dendritic cells can sense 
polymers through a mechanism involving multiple TLR/MyD88-dependent pathways 
(TLR-2, 4, 6).  These TLR-polymer interactions also induced the expression of activation 
markers (e.g. MHC II, CD80, CD86) and pro-inflammatory cytokines (e.g. IL-1β and TNF-α) 
[25].   
I.4 Angiogenesis 
Endothelial cells are one of the major cell types that are involved in the 
inflammatory and repair processes that occur after scaffold implantation. They participate 
in these processes by releasing pro-inflammatory factors and expressing cell adhesion 
molecules [44]. Endothelial cells line up the internal surface of the blood vessels that 
supply the cells in organs and tissues with oxygen and nutrients to survive and which 
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remove waste products. These cells are also the primary cells involved in the formation of 
new blood vessels from pre-existing vasculature, a process known as angiogenesis [45]. 
Vasculogenesis on the other hand, refers to the first stages of vascular development, 
through which precursor cells of vascular endothelium suffer differentiation, expansion 
and coalescence to form a network of primitive tubules in the organism [26]. Under normal 
conditions in an adult organism, angiogenesis occurs only in the reproductive cycle of 
females. Angiogenesis occurs in the uterus, with the formation of the endometrium, and in 
the ovaries, in the formation of corpora lutea. Therefore, the vascular network remains 
quiescent, but it has the capability to start angiogenesis, especially during the process of 
healing [27]. 
New vessels participate in the formation of temporary granulation tissue and supply 
nutrients and oxygen to the growing tissue. Angiogenesis, in response to tissue damage, is 
a dynamic process, fine regulated by signs present both in serum and in the local ECM. 
During the healing process, the formation of new blood vessels becomes necessary to form 
new granulation tissues, in which the blood vessel cells correspond to about 60% of the 
repair tissue. Angiogenesis occurs in the ECM of the wound bed with the migration and the 
mitogenic stimulation of endothelial cells.  
The process of angiogenesis begins with the release of angiogenic factors from MФ, 
platelets or ECM. Angiogenic factors are then transported to existing blood vessels in the 
vicinity. At the blood vessel, the angiogenic factors bind to the receptors on the endothelial 
cells. Factors such as VEGF increase vascular permeability, thereby allowing extravasation 
of plasma proteins that lay down a provisional matrix for the migrating endothelial cells 
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(Figure 5). However, excessive permeability of blood vessels is bad as it may lead to 
circulatory collapse. Angiopoietin (Ang) 2, an inhibitor of the Tie2 signaling, loosens the 
surrounding ECM by detaching smooth muscle cells. The release of matrix 
metalloproteases (MMPs) which degrade the surrounding ECM, facilitate endothelial cell 
migration and further proliferation. Ang 1, a ligand of the endothelial Tie2 receptor, does 
not initiate endothelial network organization, but stabilizes the networks presumably by 
stimulating the interaction between endothelial and periendothelial cells. Endothelial cells 
assemble as solid cords that eventually acquire a lumen.  
Finally, the newly formed vessels are stabilized by the recruitment of the 
surrounding smooth muscle cells and pericytes that provide structural support. An 
effective wound healing and long-term implant stability and survival require maintenance 
of an optimal environment for endothelial cell viability and a rapid formation of functional 
blood vessels. Angiogenic sprouting is controlled by a balance of activators and inhibitors. 
Angiogenesis inhibitors suppress the proliferation or migration of endothelial cells include 
angiostatin, endostatin, antithrombin III, interferon-β, leukemia inhibitory factor and 
platelet factor 4 [26].  
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Figure 5 The process of angiogenesis [28]. 
I.5 Electrospinning for Tissue Engineering Applications 
This section has been taken from the review article published in Biomicrofluidics, 
2011 Mar 30; 5(1):13403 entitled ‘Electrospinning jets and nanofibrous structures’.  
A number of processing techniques such as drawing, template synthesis, phase 
separation, self-assembly and electrospinning have been utilized to synthesize polymer 
nanofibers for tissue engineering. Drawing is a process that can make one-by-one very long 
single nanofibers. However, only a viscoelastic material that can undergo very strong 
deformations can be made into nanofibers through drawing. Template synthesis uses a 
nanoporous membrane as a template to make nanofibers of a solid or hollow shape. A 
major drawback of the method is the inability to synthesize one-by-one continuous 
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nanofibers. The phase separation method consists of dissolution, gelation, extraction using 
a different solvent, followed by freezing and drying. In self-assembly procedure, pre-
existing, individual components organize themselves into desired patterns and functions. 
However, both phase separation and self-assembly processes are very time consuming in 
processing continuous polymer nanofibers. Electrospinning is an advantageous processing 
method for synthesizing one-by-one continuous nanofibers from various different 
polymers [29]. It’s also a very simple, straight forward, cost-effective method to generate 
different types of scaffolds.  
The most basic electrospinning set up consists of three major components: a high 
voltage power supply, electrically conducting spinneret and collector separated at a 
defined distance (Figure 6). In the laboratory, the most common set up is the syringe that 
holds the polymer solution with a blunt tip needle as the spinneret. With the use of a 
syringe pump, the solution can be fed at a constant and controllable rate. The electrode 
from the power supply is connected to the needle holding the spinning solution to charge 
the polymer solution and the other is attached to an opposite polarity collector (usually a 
grounded conductor). When the high voltage (typically in the range of 0-30kV) is applied to 
the spinneret, the surface of the fluid droplet held by its own surface tension gets 
electrostatically charged at the spinneret tip. As a result, the drop comes under the action 
of two types of electrostatic forces: mutual electrostatic repulsion between the surface 
charges and the coulombic force applied by the external electric field. Due to these 
electrostatic interactions, the liquid drop elongates into a conical object known as the 
Taylor cone. Once the intensity of the electric field attains a certain critical value, the 
electrostatic forces overcome the surface tension of the polymer solution and force the 
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ejection of the liquid jet from the tip of the Taylor cone.  The liquid jet continues to be 
ejected in a steady manner and the surface tension causes the droplet shape to relax again. 
Before reaching the collector screen, the liquid jet elongates and solvent evaporates, 
leading to the formation of a randomly oriented, non-woven mat of thin polymeric fibers on 
the collector. Initially the solution jet follows a linear trajectory, but the jet begins to whip 
out in chaotic fashion at some critical distance from the capillary orifice. This is referred to 
as the bending instability. At the onset of this instability, the jet follows a diverging helical 
path. As the jet spirals towards the collection mechanism, higher order instabilities 
manifest themselves resulting in a completely chaotic trajectory. There are great 
advantages of using electrospinning for tissue engineering applications. Electrospinning is 
capable of producing extremely thin fibers with diameters ranging from microns down to 
few nanometers. In native tissues, cells are typically about one to two orders of magnitude 
bigger than the structural ECM proteins (50-300 nm). This allows the cells to be in direct 
contact with many ECM fibers. Therefore, the small-size fibers mimic the structural 
dimension of the ECM of several native tissues which are deposited and characterized by 
well-organized hierarchical fibrous structures realigning from nanometer to millimeter 
scale. The scaffolds produced by electrospinning possess a highly porous microstructure 
with interconnected pores and extremely high surface-area-to-volume ratio, which is 
conducive to tissue growth. In addition, it is a very versatile technique and allows the use of 
a variety of polymers, blends of different polymers, and inorganic materials. Recent 
advances in electrospinning have shown that integration of various substances such as 
additives, biomolecules, and living cells is possible in scaffolds for tailoring different 
application requirements [30]. 
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Figure 6 Basic Electrospinning set up. 
The typical approach in tissue engineering is to use electrospun scaffolds as ECM 
analogues or support substrates for the cells that have been seeded on them. The 
electrospun scaffold is then expected to facilitate the anchorage, migration and 
proliferation of the cells to reproduce the three dimensional structure of the tissue to be 
regenerated.  Electrospun scaffolds are attractive to tissue engineering because they have 
biomimetic properties, characterized by fiber diameters in the sub-micron range, large 
surface to volume ratio, high porosity, variable pore size distribution and the ability to be 
tailored into a variety of sizes and shapes. In addition, scaffold composition and fabrication 
can be controlled to match the desired properties and functionality [31-33].  A variety of 
cell-electrospun matrix interactions have been reported in the literature. Typically, the 
fiber diameters of these matrices conform to the structural properties of the ECM and are 
on the order of 80-500 nm. It has also been reported that biocompatibility of a material 
improves with decreasing fiber diameter [34]. Another parameter very crucial for cell 
growth is the degree of porosity and the average pore dimension of the nanofibrous 
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scaffold. Depending upon the cell type, the optimal pore diameters are 20-100 µm [35]. It 
has also been reported that cells are able to easily migrate to a depth of only about 100 
µm[36]. The role of fiber orientation has also been investigated. It has been observed that 
growing cells tend to follow the orientation of the fibers. In addition, the production of ECM 
is greater on oriented rather than non-oriented matrix fibers [37].  
Several natural and synthetic electrospun polymers have been used to engineer 
both hard and soft tissues. Natural polymers often lack sufficient strength upon hydration. 
The mechanical stability of these natural polymers can be improved by either cross-linking 
or mixing with synthetic polymers [38, 39]. One of the most plentiful proteins in the human 
body is collagen. Collagen fibers display several attractive biological and structural 
properties. They transmit forces, dissipate energy, prevent premature mechanical failure, 
and have high water affinity, low antigenicity and good cell compatibility [40]. Various labs 
have worked extensively on the electrospinning of collagen (Type I [41], II [42], III [43] and 
IV [43]) and blends of collagen with both synthetic and natural polymers to produce 
scaffolds for vascular [38, 44-52], skin [53-58], cartilage [59], bone [60, 61] and ligament 
[62, 63], nerve [64] tissue engineering applications. Elastin is another key protein found in 
the native ECM of connective tissues where elasticity and recoil are critical parameters.  As 
collagen and elastin are two of the most predominant proteins in the native vessel, they are 
often used together as tissue engineering scaffolds for vascular scaffolds, with or without 
synthetic polymers [50, 65-69]. Elastin has also been blended with PLA for urologic tissue 
engineering [70]. Recently, silk fibroin (SF) has gained immense popularity in the field of 
tissue engineering. SF exhibits good biocompatibility, significant crystallinity, high 
elasticity, good tensile strength, toughness and resistance to failure in compression. SF was 
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originally electrospun for ligament [71-78] tissue engineering but has also been used for 
vascular [79-81], bone [82, 83] and skin [84] tissue engineering. For a detailed review of 
both synthetic and natural electrospun polymers in tissue engineering, the readers are 
referred to the works of Sell et al. [38, 39, 85, 86], Ashammakhi et al. [32] and Kumbar et al. 
[87].   
The technique of electrospinning has also been used extensively for drug delivery 
applications. Nanofiber systems for the release of drugs are required to fulfill diverse 
functions. The matrices should be able to protect the compound from decomposition, 
should allow for controlled release in the targeted tissue, over a desired period of time at a 
constant release rate. Kenawy et al. demonstrated the release of tetracycline hydrochloride 
from electrospun matrices composed of Poly[ethylene-co-(vinyl acetate)] (PEVA), PLA, and 
a 50:50 mixture of the two polymers.  The fastest drug release was observed with PEVA, as 
compared to PLA or the blend. Burst release was observed with PLA, and release 
properties of the blend were found to be intermediate to those of the pure polymers [88]. It 
was concluded that release kinetics can be altered by changing the polymer used for the 
fabrication of the nanofibers. Other parameters that can impact the release kinetics 
include; the morphology of the fibers, their interaction with the drug  and the drug 
concentration in the fibers. It has been observed that with higher drug concentration, more 
amount of drug gets enriched on the nanofiber surface, leading to a burst release [89].  
In another study, water insoluble antitumor drug called paclitaxel and the 
antituberculosis drug called rifampin were electrospun onto PLA nanofibers. In the 
presence of proteinase K, it was found that drug release was nearly linear over time. The 
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drug release was attributed to the polymer degradation by the proteinase [90]. However, in 
the case of the hydrophilic drug doxorubicin, burst release was observed. It was reasoned 
that the hydrophilic nature of the drug caused its accumulation on the surface of the 
nanofibers, leading to burst release [91]. To circumvent this problem, Xu et al. [92] 
electrospun water-oil emulsions, in which the drug was contained in the aqueous phase 
and a PLA-co-PGA copolymer was contained in the oil phase. This method showed a 
biomodal release pattern in which burst release was observed initially through diffusion 
from the fibers, followed by linear drug release through enzymatic degradation of the 
polymer by proteinase K.  
Coaxial electrospinning technique has also been utilitized for drug delivery. In this 
system, core immobilizes the drugs and the shell controls their diffusion out of the fibers. 
Huang et al. used coaxial electrospinning to prepare PCL as the shell and two medically 
pure drugs, Resveratrol and Gentamycin Sulfate, as the cores. The drugs were released in a 
controlled way without any initial burst effect [93].  
Environmentally sensitive polymer drug delivery systems, which can release drugs 
when triggered by a stimulus (such as pH or temperature), have also been reported. 
Chunder et al. demonstrated that ultrathin fibers composed of two weak polyelectrolytes 
poly(acrylic acid) (PAA) and poly(allylamine hydrochloride) (PAH)  could be used for the 
controlled release of methylene blue (MB) through pH changes. They also showed that 
temperature sensitive drug release can be obtained by depositing temperature sensitive 
PAA/poly(N-isopropylacrylamide) (PNIPAAM) multilayers onto the fiber surfaces [94].  
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I.6 Electrospun Bioresorbable Vascular Grafts 
The native blood vessel is a highly complex and crucial organ. The complex vascular 
network of the human body serves two main functions, delivery of oxygen and nutrients to 
the tissues and removal of metabolites for clearance or re-oxygenation. As shown in figure 
7, the artery is composed of three different layers or tunics of different compositions which 
surround a hollow core or lumen through which the blood flows. The innermost layer, 
surrounding the lumen is known as the intima and is made up of single layer of endothelial 
cells on a basement membrane rich in collagen IV and elastin. This layer contacts the 
bloodstream and endothelial cells provide a crucial barrier to platelet activation by 
secreting specific molecules like nitric oxide and prevent thrombus formation. The thick 
middle layer, the media, is composed of several layers of smooth muscle cells in an 
extracellular matrix of collagen types I and III, elastin and proteoglycans. In elastic arteries 
like the aorta, the elastic lamellae allow the artery to maintain sufficient blood pressure 
with variations in hemodynamic stress of the cardiac systole and diastole. In muscular 
arteries, elastin is assembled as fibers. The outermost adventitial layer is composed of 
fibroblasts and randomly arranged collagen type I.  This, collagen provides tensile support 
and prevents vessel rupture. The proteoglycans contribute to the compressibility and the 
elastin fibers give elasticity to the vessel and provide the ability to recover from pulsatile 
deformations. Its elastic nature dominates the low strain mechanical response of the vessel 
to blood flow and prevents pulsatile energy from being dissipated as heat The ideal 
vascular prosthetic must have the following performance characteristics: ease of handling, 
suture retention, ease of suture replacement, flexibility with kink resistance, 
biocompatibility, durability after implantation and association with surrounding 
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connective tissue, compliance matching that of the native artery, and resistance to 
aneurysm formation. Also, the graft must be easily manufactured, economical, easily stored 
and available in a variety of sizes [7].   
Initial graft research focused on Poly(ethylene terephthalate) (Dacron) and 
expanded poly(tetrafluoroethylene) (e-PTFE) as prosthetic vascular grafts. Both Dacron 
and e-PTFE react with blood components and perigraft tissues in both advantageous and 
injurious ways. It has been documented that monocytes and macrophages produce 
cytokines such as IL-1β, IL-6, and TNF-α when incubated with Dacron and e-PTFE [8]. 
However, these prostheses remained permanently within the host after implantation. The 
concept of a slowly absorbable graft that could stimulate rapid and controlled regenerative 
process producing a “neoartery” was first described by Wesolowski et al. [9] and 
Ruderman et al. [10]. These grafts were partially bioresorbable and composed of Dacron 
and polylactide yarns. Bowland et al. described the use of Vicryl (a copolymer of 
polyglycolide and polylactide) as a fully bioresorbable vascular graft [11]. These early 
grafts were susceptible to aneurismal rupture and dilation.  
Greisler et al. evaluated woven poly (glycolic acid) (PGA) grafts in a rabbit model. 
Four weeks after implantation, these grafts were shown to contain an inner capsule 
composed of a confluent layer of endothelial cells and smooth muscle like myofibroblasts in 
the midst of dense collagen fibers. Similarly constructed and implanted Dacron grafts failed 
to show the results described above [12, 13]. It is also important for the bioresorbable graft 
to regenerate a complex tissue of sufficient strength before prosthetic degradation so as to 
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Figure 7 Architecture of the native artery. 
 
minimize the risk of aneurismal dilation. To circumvent this problem two or more 
bioresorbable materials with different resorption rates can be combined so that the more 
rapidly absorbed material induces rapid tissue ingrowth while the second material 
provides structural support [14]. Such composite grafts containing 69% polyglactin 910 
(PG910) and 31% polypropylene were implanted into rabbit and dog arteries [15]. These 
grafts demonstrated 100% one-year patency with no aneurysms. In another study, 
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composite grafts of 74% PG910 and 26% polydioxanone (PDO/PDS) also showed 100% 
patency with no aneurysms one year after implantation [16]. PDO is a colorless, crystalline, 
biodegradable polymer that was developed for wound closure sutures. It exhibits high 
flexibility, higher strength retention, slower absorption rate, and lower inflammatory 
response as compared to poly(glycolide lactide) and poly(glycolic acid) [7].  Greisler et al. 
published results utilizing PDO absorbable vascular prosthetics in a rabbit aortic model of 
regeneration. The results showed no perigraft hematomas and the myofibroblast migration 
paralleled the macrophage–mediated degradation of the PDO structure. A confluent EC 
lining was present within two weeks, with the compliance of the explants at 1 year 
resembling an artery [17]. Greisler et al. demonstrated that PDO grafts had the highest 
production ratio of PGI2/TxA2 at a seven fold increase versus PGA and approximately 
equal to the native aorta control. The study showed a tissue dependence response in terms 
of thrombogenicity and the grafts containing PDO were less thrombogenic [18]. PDO can be 
reproducibly electrospun. It is readily dissolvable in 1,1,1,3,3,3-hexafluoro-2-propanol 
(HFP) and has been electrospun at concentrations between 42 and 167 mg/ml, producing 
fibers diameters ranging from 180 nm to 1.4 μm respectively. Uniaxial tensile testing 
performed on PDO revealed a modulus ranging from 2.0 to 46 MPa, a peak stress ranging 
from 1.7 to 12.0 MPa, and a percent strain at break ranging from 31 to 240% [7, 19]. 
I.7 Pore-size/Porosity: a crucial material property for tissue regeneration 
From the early stages of vascular prosthetic use, porosity emerged as the design 
focus, out-ranking material properties.  The complex nature of most prosthetic designs 
makes it difficult to determine the “porosity” or basic void space requirements (defined by 
29 
 
water permeability) for healing and transmural endothelialization.  In many prosthetic 
designs, it has been seen that the porosity is supportive of MФs and other inflammatory 
cells to infiltrate, but connective tissue cells (similar cell diameters) were noticeably 
absent.  It was determined that the connective tissue cells (i.e. smooth muscle cells) trail 
the endothelial cells (ECs) during healing.  Thus, an important prosthetic design variable is 
that the wall pores permit capillaries (average 10 µm diameter) to sprout while leaving 
room for accompanying cells to trail.    
Pore size, pore interconnectivity, and net porosity have always been a focus of tissue 
engineering scaffolds and have been shown to be key determinants of a scaffold’s success 
through their influence on cell infiltration, nutrient/oxygen exchange, and angiogenesis 
[95, 96].  The success of electrospun scaffolds has been minimal due to the inability to 
directly control pore size and overall net porosity due to fiber diameters and the 
subsequent tight packing of the fibers.  Because the fine pore structure restricts cell 
migration into the structure, it has been suggested that the pore size should at least be the 
size of the cell of interest to allow infiltration [66, 97, 98].  An additional challenge is that 
the “optimal” pore size for cell adhesion, proliferation and migration varies by material 
composition and cell type from 5 to 500 µm [99].  A review by Szentivanyi et al. [100] 
showed that for electrospun scaffolds composed of 0.25 and 2 µm diameter fibers that a 10-
50 µm pore size was necessary for cell infiltration.  Above 2 µm diameter fibers (resulting 
pore size >10 µm [97]), the scaffolds were all conducive to cell infiltration.  In order to get 
50 µm pores, Pham et al. [97] showed that one needs 10 µm diameter fibers (pore size is a 
function of fiber diameter).  Electrospun scaffolds composed of submicron diameter fibers 
generally result in pore dimensions of 1-5 µm.  Thus, a fabrication technique that offers 
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direct control of pore dimension, yet allows for the use of submicron diameter fibers 
without significantly compromising structural integrity is needed.  In terms of maximizing 
angiogenesis, it has been suggested that optimal physical properties (i.e. pore size, 0.8 to 8 
µm) are critical [101].  Soliman et al. [102] showed for electrospun PCL that a 50-60 µm 
pore size enhanced EC infiltration versus a scaffolding composed of 10 µm pores (no 
infiltration).  Lowery et al. [103] showed an optimal pore size of 6-20 µm (±50% seeded 
cell diameter) for electrospun PCL with cells unable to bridge the gaps in larger pores 
between fibers.  
To overcome electrospun scaffold pore size limitations, scaffolds composed of 
blended synthetic and natural polymers (native integrin binding sites) have been created 
[104-106].  While cell adhesion was enhanced, these structures had limited success in 
improving cellular infiltration.  The use of porogens in electrospun scaffolds has also been 
utilized.  Zhang et al. electrospun a blend of PCL and gelatin without cross-linking, allowing 
a large percentage of the gelatin to dissolve when immersed in an aqueous media [30]. 
Baker et al. electrospun poly(ethylene oxide) (PEO) fibers intermingled with 
simultaneously electrospun PCL fibers, with the water-soluble PEO “sacrificial fibers” 
removed by post-processing [107].  Results showed that the greater the PEO in the scaffold, 
the greater the cellular infiltration (majority of cells remained in the upper 25%) but at the 
expense of a significant reduction in the scaffolds’ modulus and maximum stress.  Nam et 
al. introduced salt crystals amongst the fibers that were removed by post-processing to 
create void areas that enhanced cell infiltration [108]. The major concerns with this 
method include the uneven distribution of crystals and loss of scaffold integrity 
(macroscopic scaffold delamination).  The common result of these studies is that enhanced 
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porosity/cell infiltration comes at the expense of decreased mechanical properties/scaffold 
integrity.  McClure et al. [109] recently published a method for scaffold fabrication that 
allows consistent control over electrospun scaffold porosity by the use of an air flow 
impedance mandrel. The scaffolds’ fabricated possess two seemingly contradictory 
properties by having both 1) porous regions which permit rapid cell infiltration, and 2) 
dense fiber regions which are less amenable to cell infiltration, but which provide ample 
structural integrity.  Scaffolds with these properties are made using a mandrel that is 
perforated.  During the electrospinning process, as fibers are deposited onto the perforated 
mandrel, pressurized air emanating from the mandrel perforations is introduced into the 
developing fibrous structure that are located at or near the perforation, causing the fibers 
in those areas to be less dense, creating regions of increased scaffold porosity.  In contrast, 
fibers deposited on solid, non-perforated sections of the mandrel (e.g. located between and 
adjacent to the perforations) are, in comparison, densely packed. The scaffold thus contains 
regions in which the fibers are porous and regions in which the fibers are densely packed, 
all within a single contiguous, seamless structure prepared during a single deposition 
event, thus not requiring multiple deposition steps and/or processing steps.  This now 
overcomes the major limitation pertaining to the lack of control over scaffold porosity and 
potentially creates an environment (defined fiber diameters and scaffold porosity) capable 
of promoting MФ-mediated angiogenesis and in situ tissue regeneration.     
I.7 Hypothesis and Thesis Objectives 
The host response to implanted biomaterials is a complex multi-step process 
consisting of various different cell types. MФ can play both beneficial and detrimental roles 
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in the process of tissue remodeling due to their inherent plastic nature. An essential and 
timely phenotypic switch is required for proper and functional remodeling of the tissue as 
opposed to a scar tissue outcome with a loss of function. Thus, MФ can decide the fate of 
the implanted biomaterial. Mast cell is another important cell type in the context of tissue 
healing. Mast cells participate in the early stages of wound healing and modulate the acute 
inflammatory responses to biomaterials. Mast cells can secrete a myriad of different 
cytokines by the process of degranulation; the process of regulated secretion in which 
preformed contents stored in their granules are rapidly released by exocytosis. Some of 
these cytokines such as IL-4, IL-13 and TNF-α can modulate the MФ phenotype. The 
phenotypic profile of MФ as M1 or M2 following exposure to the biomaterial (electrospun 
PDO) can dictate the downstream processes of tissue remodeling and angiogenesis. MФ 
participating in the host response to an implanted biomaterial are exposed to numerous 
cytokines and effector molecules secreted by several types of cells. In addition, MФ are also 
exposed to microbial agents, epitopes associated with the implanted biomaterial and the 
degradation products of the biomaterial. The host MФ response is modulated via “cross-
talk” between MФ and other cells (e.g. endothelial cells) as well as factors within the local 
environment.  Therefore, a complete understanding how mast cells and MФ interact with 
biomaterials is crucial. 
This thesis aims to gather insight into the mast cell and MФ activity on electrospun 
biomaterials. A detailed analysis of mast cell interaction with electrospun PDO, PCL and 
Silk is given in Chapter 2. The adhesion, proliferation and cytokine secretion of mast cells 
on electrospun bioresorbable grafts was investigated in the presence or absence of IL-3, 
SCF, IgE and IgE with a crosslinking antigen, DNP. We attempted to modulate the behavior 
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of mast cells on electrospun scaffolds by adding these stimulating agents using tissue TCP 
as the control. The stimulating agents were chosen and combined according to their 
proliferation and attachment-inducing potential. The hypothesis in this study is that mast 
cells would secrete more pro-M2 or pro-wound healing cytokines after interacting with 
biomaterials and would thereby assist MФ and other cell types in tissue remodeling. 
The next study (Chapter 3) involves the identification of the macrophage phenotype 
(M1 or M2) promoted by electrospun PDO of varying fiber diameter, pore-size, surface area 
to volume ratio and porosity. The hypothesis in this study is that differences in pore-size 
and fiber diameters of electrospun PDO would modulate MФ phenotype (M1/M2) and thus 
influence the MФ mediated angiogenesis and regeneration. A relationship between the 
M1/M2 profile of MФs and the downstream angiogenic responses has also been 
determined using a 3D angiogenesis bead assay described previously [110]. This study is 
described in detail in Chapter 4. We hypothesized that the bigger fiber/pore-size PDO 
scaffolds would shift the MФs to a functionally active M2-like phenotype, which would 
support angiogenesis. 
We have also tried to understand the signaling mechanism by which PDO composed 
of small or large fiber/pore-size signals MФ phenotypic responses in Chapter 5. The 
potential candidates tested in this study were MyD88 and TLR4. The hypothesis for this 
study was that materials with different fiber/pore-sizes would signal through different 
mechnisms. A complete understanding of these signaling mechanisms would allow for 
development of strategies that control the regeneration of biomaterials in vivo. 
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In order to evaluate the angiogenic and regeneration potential of electrospun PDO in 
vivo, we used a subcutaneous directed in vivo angiogenesis assay. We hypothesized that 
electrospun PDO of bigger fiber/pore-size would lead to greater angiogenic response in 
vivo. Furthermore, immunostaining of electrospun PDO would allow for quantification of 
M1:M2 phenotype ratios. We expected the bigger fiber/pore-size PDO would support a 
predominately M2 phenotype compared to the small fiber/pore-size PDO. 
Recognition of the predominant MФ phenotypic profile will provide a tool by which 
a tissue regenerative outcome can be predicted and possibly promoted [111]. Overall, these 
studies would provide an insight into the mechanisms by which biomaterials heal. These 
studies would allow biomedical researchers to create better materials for tissue 
engineering, that self-heal and integrate with the host tissue without any undesirable 
immune reactions. 
 
 
 
 
 
 
 
35 
 
 
 
 
Chapter II: Modulation of Mast Cell Adhesion, 
Proliferation and Cytokine Secretion on 
Electrospun Bioresorbable Vascular Grafts 
 
This study has been published in the Journal of Biomedical Materials Research 
Part A, 2011, 97(4):405-13. 
 
 
Koyal Garg*, John J. Ryan# and Gary L. Bowlin* 
*Department of Biomedical Engineering, Virginia Commonwealth University 
#Department of Biology, Virginia Commonwealth University 
 
 
 
 
 
 
 
36 
 
II.1 Abstract 
Mast cells synthesize several potent angiogenic factors and can also stimulate 
fibroblasts, endothelial cells and macrophages. An understanding of how they participate in 
wound healing and angiogenesis is important to further our knowledge about in situ 
vascular prosthetic regeneration. The adhesion, proliferation and cytokine secretion of 
bone marrow derived murine mast cells (BMMC) on electrospun polydioxanone (PDO), 
polycaprolactone (PCL) and silk scaffolds, as well as tissue culture plastic (TCP) has been 
investigated in the presence or absence of IL-3, SCF, IgE and IgE with a crosslinking 
antigen, dinitrophenol-conjugated albumin (DNP). It was previously believed that only 
activated BMMCs exhibit adhesion and cytokine secretion. However, this study shows non-
activated BMMC adhesion to electrospun scaffolds. Silk scaffold was not found to be 
conducive for mast cell adhesion and cytokine secretion. Activation by IgE and DNP 
significantly enhanced mast cell adhesion, proliferation, migration and secretion of TNF-α, 
MIP-1α and IL-13. This indicates that mast cells might play a role in the process of 
biomaterial integration into the host tissue, regeneration, and possibly angiogenesis. 
II.2 Introduction 
An understanding of how mast cells participate in angiogenesis is important to 
further our knowledge about vascular development and remodeling [112]. Mast cells are 
important to the pathogenesis of allergic, autoimmune and cardiovascular diseases, and 
cancer. However, in addition to playing a critical role in host defense, they are also involved 
in various physiological processes such as angiogenesis, tissue remodeling and collagen 
production [113-116].  
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Biological responses to implanted materials involve neutrophil mediated 
detoxification, followed by macrophage activity to phagocytize debris and coordinate 
remodeling events. It was reported by Ashley et al. that these events occur in the presence 
of both eosinophils and mast cells [15]. They are known to mediate acute inflammatory 
responses to the implanted biomaterials [1]. Mast cell-derived Interleukin-4 (IL-4) and IL-
13 were found to induce macrophage fusion while tumor necrosis factor alpha (TNF-α) was 
responsible for biomaterial adherent macrophage apoptosis. IL-4 and IL-13 lead to 
alternatively activated macrophages which play a role in allergic responses, elimination of 
parasites and matrix remodeling [13].  Using implantation of fibrinogen coated 
polyethylene terephthalate (PET) disks in mice, it was found that this biomaterial triggers 
the activation of mast cells shortly after implantation, releasing granular products 
including histamine. Mast cell-deficient mice exhibited reduced phagocyte accumulation on 
the implants. Administration of histamine receptor antagonists also greatly decreased 
recruitment and adhesion of neutrophils and monocytes/macrophages to implants [117].  
Mast cells can be activated by physical stimuli, immunogenic stimuli 
(Immunoglobulin E (IgE), complement, cytokines and growth factors) and neurogenic 
stimuli (neuropeptides) [113]. Exposure of mast cells to an allergen leads to cross linking 
of the IgE-loaded surface receptor, FcɛRI, with at least three biological effects. First, they 
can undergo degranulation; the process of regulated secretion in which preformed 
contents stored in their granules are rapidly released by exocytosis. Granule associated 
mediators include proteases, histamine, proteoglycans and cytokines such as TNF-α and IL-
16. Following degranulation is the rapid enzymatic synthesis of lipid mediators derived 
from precursors stored in the cell membranes and in lipid bodies. These include, the 
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arachidonic acid metabolites prostaglandin (PG) D2, leukotrienes (LT) B4+ and C4, and 
platelet activating factor (PAF). Lastly, activated mast cells initiate transcription, 
translation and secretion of a variety of cytokines and chemokines depending on the mast 
cell type and stimulus. These include, TNF-α, granulocyte-macrophage colony-stimulating 
factor (GM-CSF), stem cell factor (SCF), IL-3, IL-4, IL-5, IL-6, IL-10, IL-13, IL-14 and IL-16, 
and chemokines, such as macrophage inflammatory protein (MIP)-1α, MIP-1β, T-cell 
activation gene 3, lymphotactin and monocyte chemoattractant protein -1 (MCP-1) [118-
121]. Under physiological conditions in several organs, mast cells are found in close vicinity 
to capillaries and lymphatic vessels and a direct correlation between the number of mast 
cells and blood vessel density  has been demonstrated in the dermis[122]. Mast cells 
synthesize several potent angiogenic factors such as vascular endothelial growth factor 
(VEGF), basic fibroblast growth factor (bFGF), heparin, histamine, tumor necrosis factor 
(TNF-α) and IL-8. On the other hand, endothelial cells may also express the mast cell 
growth and chemotactic factor, SCF. This shows that endothelial cells may also elicit mast 
cell chemotaxis and survival, demonstrating a two way relationship between them [123, 
124]. It has been shown that SCF is the primary cytokine involved in mast cell 
differentiation and activation [125-128]. SCF (or c-kit ligand) is critical for mast cell 
survival, as mast cells cultured without SCF undergo apoptosis [129]. In addition to acting 
on the vasculature, mast cells may augment wound healing by promoting extracellular 
matrix deposition. In fibroblasts, mast cell extracts elicit collagen synthesis and activate an 
enzyme involved in matrix remodeling; gelatinase A [130]. The addition of histamine to 
cultured fibroblasts has been shown to stimulate proliferation and collagen synthesis [131, 
132].  It has also been reported that tryptase, which is abundantly expressed in mast cells, 
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can act as a growth factor for human fibroblasts and can stimulate collagen type I synthesis 
[133]. Similar to mast cell-endothelial cell interactions, mast cells can be attracted to 
fibroblasts via their SCF expression as both membrane-bound and secreted forms. 
In this study, an investigation of mast cell interaction with electrospun scaffolds has 
been performed. The biomaterials chosen for this study were polycaprolactone (PCL), PDO, 
and silk fibroin (silk). PCL exhibits properties (i.e. compliance) that are conducive to 
arterial tissue engineering with an extended degradation time, and compatibility for 
endothelial cells and smooth muscle cells [106, 134-136]. PDO has been extensively studied 
by our laboratory and has shown promise in vitro [105, 106, 137-141]. Its flexibility, 
excellent strength retention, shape memory, low inflammatory response and slow 
degradation rate make it a suitable candidate for vascular tissue engineering. The use of 
silk as a vascular tissue engineering scaffold has escalated recently. Zhang et al. 
demonstrated the bioactivity of human aortic endothelial cells and human coronary artery 
smooth muscle cells on electrospun silk [142]. It was established by Soffer et al. that 
electrospun tubular silk constructs can withstand native arterial pressures while behaving 
in a similar manner to native vessels during creep testing [143].  
The adhesion, proliferation and cytokine secretion of mast cells on electrospun 
bioresorbable grafts was investigated in the presence or absence of IL-3, SCF, IgE and IgE 
with a crosslinking antigen, dinitrophenol-conjugated albumin (DNP). We attempted to 
modulate the behavior of mast cells on electrospun scaffolds by adding these stimulating 
agents using tissue culture plastic (TCP) as the control. The stimulating agents were chosen 
and combined according to their proliferation and attachment-inducing potential. It is 
widely accepted that IL-3 alone is capable of maintaining mouse mast cell survival. 
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However, SCF is required for mast cell attachment to substrates. The presence of IgE and 
antigen can further enhance the survival and attachment of mast cells induced by IL-3 and 
SCF. The results of various studies show conflicting reports on the effects of IgE in the 
absence of antigen. Its impact on mast cell survival and attachment has not been clearly 
defined yet [144]. Overall, our data demonstrate mast cell adhesion, survival and IgE 
responsiveness when cultured with bioresorbable polymers, supporting the utility of these 
polymers in tissue grafts.  
II.3 Materials and Methods 
II.3.1 Electrospinning  
Electrospinning was used to generate nanofibrous scaffolds of PCL, PDO, and silk.  
Silk fibroin was extracted from the cocoons of Bombyx mori silkworms (The Yarn Tree) 
through an established protocol [145]. PCL (MW 60,000 kDa, Sigma Aldrich), PDO (Ethicon, 
Inc.) and silk polymer concentrations used in the study were 250, 100 and 100 mg/ml 
respectively in 1,1,1,3,3,3, Hexafluoro-2-propanol (HFP) to form flat sheets on a stainless 
steel mandrel (0.5 cm x 3cm x 15 cm). Disks 6 mm in diameter were punched out of these 
scaffolds and were placed in a 96 well plate. Fibronectin (100 μl) at a concentration of 50 
μg/ml was added on top of the disk and the plate was allowed to sit in the incubator at 
37°C for an hour. After an hour, the disks were moved to a new well. The scanning electron 
micrographs of the uncoated scaffolds are shown in Figure 9.  
II.3.2 Cell Culture and Seeding 
Bone marrow derived murine mast cells (BMMCs) were derived from C57BL/6 mice 
as described previously [146]. Briefly, BMMC cultures were derived from bone marrow 
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harvested from C57BL/6 mouse femurs and tibias (Jackson Labs, Bar Harbor, ME).  BMMC 
cultures were maintained in cRPMI supplemented with IL-3 containing supernatant from 
WEHI-3B and SCF containing supernatant BHK-MKL cells. The final concentration of IL-3 
and SCF was adjusted to 1 ng/ml and 10 ng/ml, respectively [147]. After 3-4 weeks in 
culture, these populations were >99% mast cells, as judged by morphology and flow 
cytometry staining for expression of FcɛRI, and Kit (data not shown).  The resulting 
populations were generally used between weeks 4-12. The cells were rinsed with 
phosphate buffered saline (PBS) and cultured in complete RPMI (cRPMI) 1640 medium 
(Invitrogen Life Technologies) (10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 
µg/ml streptomycin, 1 mM sodium pyruvate, and 1 mM HEPES; Biofluids), supplemented 
with 5 ng/ml of  IL-3 (R&D systems) and 50 ng/ml of  SCF (PeproTech) . The cells were 
then divided into four groups and cultured for 18 hours in the presence of IL-3 (group 1), 
IL-3+SCF (group 2) and IL-3+SCF+IgE (1µg/ml, clone C38-2, BD Biosciences) (group 3). 
After 18 hours, Group 3 was centrifuged and suspended in media containing dinitophenyl-
human serum albumin (DNP) antigen (100 ng/ml, Sigma-Aldrich) (group 4). This was done 
to cross link the IgE-loaded cell surface receptor FcɛRI, triggering BMMC activation prior to 
scaffold seeding.  
II.3.3 Cell Adhesion  
Disks 6 mm in diameter were punched from the scaffolds, disinfected (by soaking in 
ethanol for 10 min followed by repeated rinses in PBS) and placed in a 96 well plate. Each 
disk was then coated with 100 µl of fibronectin (50 µg/ml) and placed in the incubator at 
37°C for an hour. The disks were then moved to a clean well and BMMCs were seeded on 
fibronectin-coated electrospun PDO, PCL, and silk scaffolds and uncoated tissue culture 
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plastic (TCP) under four different culture conditions. The culture conditions were; cRPMI 
media supplemented with IL-3 (group 1), IL-3+SCF (group 2), IL-3+SCF+IgE (group 3) and 
IL-3+SCF+IgE+DNP (group 4) as described in section 2.2. In all groups, mast cells were 
seeded at a density of 50,000 cells/well with 170 µL of media. The cells were allowed to 
attach for 7 hours in the incubator. At 7 hours, the cell seeded scaffold was moved to a 
clean well and the number of attached cells was quantified by MTS assay as described 
below. 
II.3.4 Cell Proliferation  
The numbers of cells on the scaffold were determined with a colorimetric cell titer 
assay (CellTiter 96® AQueous; Promega Corp., Madison, WI). The assay is composed of 
solutions of a tetrazolium compound, MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] and an electron coupling 
reagent, PMS (phenazine methosulfate). Metabolically active cells convert MTS into the 
aqueous soluble formazan product. The quantity of formazan product can be measured by 
the amount of 490 nm absorbance. It is directly proportional to the number of living cells in 
culture. For this assay, disks 6 mm in diameter were punched from the scaffolds, 
disinfected (by soaking in ethanol for 10 min followed by repeated rinses in PBS) and 
placed in a 96 well plate. Each disk was then coated with 100 µl of fibronectin (50 µg/ml) 
and placed in the incubator at 37°C for an hour. The disks were then moved to a clean well 
and BMMCs were seeded on fibronectin-coated electrospun PDO, PCL, and silk scaffolds 
and uncoated tissue culture plastic (TCP) under four different culture conditions. The 
culture conditions were; cRPMI media supplemented with IL-3 (group 1), IL-3+SCF (group 
2), IL-3+SCF+IgE (group 3) and IL-3 + SCF +IgE+DNP (group 4) as described in section 2.2. 
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In all groups, mast cells were seeded at a density of 50,000 cells/well with 170 µL of media. 
In order to exclude any cells attached to TCP, the scaffold disks were moved to a new well 
plate and 100 μl of fresh media with 20% MTS solution (20 μl) was added and placed in the 
incubator for 2 hours. Simultaneously, standards were made with mast cells starting with a 
concentration 200,000 cells/well to zero (media alone).  The number of cells was 
determined by interpolation from the standard curve by using a log-log fit. The assay was 
performed on day 1, 3 and 5. Each data point was calculated from triplicate wells. 
II.3.5 Histology 
For histological evaluation, disks of PDO, PCL and silk of all four groups were fixed 
in formalin on day 3. The paraffin embedded disks were cross-sectioned and stained with 
hematoxlin and eosin (H&E) to examine cell infiltration into the scaffolds. 
II.3.6 Quantification of TNF-α, MIP-1α and IL-13 
10 mm disks (disinfected) of fibronectin-coated (50 µg/ml) electrospun PDO and 
PCL scaffolds were placed in a 48 well plate and an 8 mm cloning ring was placed on top of 
the scaffolds to retain the cells during scaffold seeding within a defined circumference. 
Cells were seeded on fibronectin-coated electrospun PDO, PCL, and silk scaffolds and 
uncoated tissue culture plastic (TCP) at a concentration of ~1x106 cells/ml. Media was 
added in the center of each scaffold (100 μl of cells in media incubated for 45 min and 
followed by 200 μl of media). Cell culture supernatants were collected after 24 hours and 
stored frozen at -20°C until analyzed by enzyme linked immunosorbent assay (ELISA). The 
amounts of TNF-α, MIP-1α, IL-13 (PeproTech) secreted by the mast cells due to their 
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interaction with the electrospun scaffold were quantified by ELISA as per the 
manufacturer’s instructions.  
II.3.7 Statistical Analysis 
Data expressed in this paper is in the format of means ± standard error of mean 
(S.E.M). Data of one representative experiment carried out in triplicates are given. Each 
experiment was reproduced at least twice. All statistical analysis of the data was based on a 
Kruskal-Wallis one-way analysis of variance on ranks and a Tukey-Kramer pairwise 
multiple comparison procedure (α=0.05) performed with JMP®IN 8 statistical software 
(SAS Institute). 
II.4 Results 
II.4.1 Mast Cell Adhesion and Proliferation  
The percentage of adherent mast cells at the end of 7 hours on polymeric scaffolds 
and TCP are shown in Figure 10. On PCL, PDO and TCP, cells exposed to IgE alone (group 3) 
displayed greater attachment as compared to group 1 (IL-3) and group 4 (IL-
3+SCF+IgE+DNP). Silk exhibited little to no attachment in all groups. SCF +IL-3 (group 2) 
promoted cell attachment at levels comparable to IgE on TCP and PDO.  
Mast cell proliferation on the three scaffolds and TCP was studied at day 1, 3 and 5 
with the results shown in Figure 11. Cells stimulated with IgE+DNP (group 4) showed 
significantly higher proliferation on day 5 as compared to groups 1 and 3 on the PCL and 
PDO scaffolds. By day 5, the group 4 cells proliferated 2-fold on PCL, 1.7-fold on PDO and 
3.3-fold on TCP. Exposure of mast cells to IgE+DNP leads to cross linking of the IgE-loaded 
surface receptor FcɛRI. Figure 3 demonstrates that although mast cells exposed to IgE+DNP 
45 
 
initially adhered less than the cells exposed to IgE alone, antigen stimulation allowed for 
enhanced proliferation and a net gain in cell numbers over the IgE alone group. In fact, IgE 
in the absence of antigen did not support long-term proliferation and survival of mast cells 
in this assay. It has been reported that FcɛRI aggregation enhances mast-cell proliferation, 
perhaps owing to the autocrine effects of IL-3 and IL-4 [148]. Our data are consistent with 
these findings. 
SCF is a powerful mast cell co-mitogen. Mast cells treated with IL-3+SCF (Group 2) 
showed a steady increase in proliferation from day 1 to day 5 for the PDO and PCL scaffolds 
as well as TCP. Two pieces of data from figure 3 were notable. First, IgE crosslinkage was a 
stronger mitogen than SCF when used in the presence of PDO or PCL. Second, silk not only 
offered poor adhesion (Figure 2) but also failed to support mast cell proliferation even in 
response to SCF or IgE crosslinkage. These data demonstrate the differential ability of the 
polymer substrates to support mast cell adhesion and expansion. 
 
 
Figure 8 SEM images of PCL (left) PDO (middle) and silk (right). 
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Figure 9 Adherent cells expressed as percentage of seeded cells after 7 hours of culture. 
Symbols ‘Ψ’ indicate a statistically significant difference from group 1 (IL3) and group 4 
(SCF+IL-3+IgE+DNP) for a particular material. Symbol ‘Φ’ indicates statistical difference 
from all groups for that particular material. 
 
Figure 10 Mast cell proliferation on scaffolds and TCP. Symbols ‘Ψ’ indicate a statistically 
significant difference from group 1 (IL-3) and group 3 (SCF+IL-3+IgE) for a particular 
material. Symbol ‘Φ’ indicates statistical difference from all groups for that particular 
material. 
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II.4.2 Histology  
H&E staining revealed cell infiltration into the fibrous structures of PDO (Figure 
12h) and PCL (Figure 12d) on day 3. Consistent with the poor cell binding in short-term 
assays, no cells were observed on the silk scaffold using H&E staining (Figure 12i, j, k, l). 
Mast cell adhesion molecules include various integrins, intercellular adhesion molecule-1 
(ICAM1) and c-kit. It has been shown that mast cells adhere to plate bound laminin, 
fibronectin and vitronectin only when activated through FcɛRI or by pharmacological 
stimuli such as phorbol 12-myristate-13-acetate (PMA) or calcium ionophore [149-152]. 
However, mast cells exposed to only IL-3+SCF attached to the PDO and PCL scaffolds. This 
proves that a combination of fibronectin, SCF and the scaffold nanostructure can elicit mast 
cell attachment. Consistent with Figure 2, mast cells exposed to IgE alone attached to the 
scaffold in greater numbers than IL-3+SCF (Figure 12b, c). It has been demonstrated that 
IgE primes mast cell adhesion to fibronectin using similar pathways as IgE +Ag [153].   
As noted when studying proliferation in Figure 3, IgE+DNP stimulation led to the 
greatest number of adherent mast cells after 3 days of culture with PDO (Figure 12d) or 
PCL (Figure 12h). The increased number of cells is likely due both to strong adhesion and 
cell division. The histology analysis also revealed an important difference between the 
stimuli. In the presence of SCF, mast cells remained largely on the surface of the 
electrospun scaffold. However, in the presence of IgE+DNP, cellular infiltration 
dramatically improved. The cells migrated deeper into the fibrous structures of PDO and 
PCL scaffolds. These data suggest that FcɛRI aggregation is a potent stimulus for mast cell 
attachment, proliferation and migration in the presence of electrospun bioresorbable graft 
structures. 
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Figure 11 H&E staining of mast cell seeded PCL, PDO and silk scaffolds on day 3. The blue 
arrows indicate the seeded surface. 
 
II.4.3  Mast Cell Cytokine Secretion 
To assess the functionality of mast cells adhered to electrospun scaffolds, we 
measured cytokine secretion. Mast cells secrete an array of cytokines and chemokines. We 
chose to measure TNF-α (Figure 13), MIP-1α (Figure 14) and IL-13 (Figure 15), which are 
well known for their roles in mast cell mediated inflammation [154-165]. IL-3 alone group 
and silk scaffold were omitted from this study due to their poor capacity for cell adhesion 
and proliferation. When compared to the background (media alone), only group 4 cells (IgE 
+ DNP) produced any cytokines on the PDO and PCL substrates. While IL-3 and SCF are 
strong mast cell mitogens, neither is a potent inducer of cytokine secretion as a sole 
stimulus. In keeping with this, IgE+DNP was the only stimulus to consistently elicit 
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cytokine production on PDO, PCL and TCP. More importantly, mast cells cultured on PDO or 
PCL showed similar cytokine responses to the control group cultured on TCP. These data 
indicate that mast cell adhesion to bioresorbable polymers did not hinder their 
functionality.  
 
 
Figure 12 Production of TNF-alpha by mast cells on electrospun scaffolds. Symbol ‘*’ 
indicates statistical difference from all groups for that particular material. 
 
 
 
 
 
 
50 
 
 
Figure 13 Production of MIP-1alpha by mast cells on electrospun scaffolds. Symbol ‘*’ 
indicates statistical difference from all groups for that particular material. 
 
Figure 14 Quantification of IL-13 release by ELISA on day 1. Symbol ‘*’ indicates statistical 
difference from all groups for that particular material. 
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II.5 Discussion 
One of the main requirements of tissue engineered scaffolds is to provide cells with 
a suitable environment for cell attachment, which is the first step in the cellular growth 
process. The use of electrospinning for fabricating nanofibrous tissue engineering scaffolds 
has escalated at a dramatic rate in the recent years. Electrospinning is capable of producing 
fibers in micro/nanometer range, which mimic the structural dimension of the native 
extracellular matrix (ECM). The scaffolds produced by electrospinning possess a highly 
porous microstructure with interconnected pores and extremely high surface-area-to-
volume ratio, which is conducive to cellular growth, attachment and organization [166]. 
Material interaction with the cells is guided by its physicochemical surface properties 
[167].  Surface modifications of the electrospun scaffolds can drastically improve the 
biological performance while retaining all the nanostructure features and properties [168]. 
He et al. fabricated a collagen coated poly (L-lactic acid)-co-poly(ɛ-caprolactone) scaffold 
that exhibited enhanced spreading, viability and attachment of endothelial cells (EC) [47]. 
It was observed in another study that fibronectin coating of polymeric substrates was 
required for Human Umbilical Vein Endothelial Cell (HUVEC) attachment and spreading 
[167]. In this study, fibronectin coating was found to be imperative for mast cell 
attachment and spreading on the electrospun scaffolds (data not shown). Plasma 
fibronectin modulates the foreign body response and fibrous encapsulation of implanted 
materials [169]. Cellular transmembrane integrin receptors recognize the Arginine-
Glycine-Aspartic acid (RGD) sequences within fibronectin. Once integrins bind to 
fibronectin, they activate a cascade of intercellular signaling pathways [167, 170].  
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It has been documented that human mast cells attach to fibronectin and vitronectin 
only when stimulated by phorbol 12-myristate 13 –acetate (PMA) and or calcium 
ionophore [150]. In another study, it was found that following FcɛRI-mediated activation 
mast cells exhibited flattening and spreading accompanied by cell translocation on laminin, 
fibronectin and matrigel [149]. However, in this study mast cells adhered to fibronectin-
coated electrospun scaffolds in the presence of SCF and IL-3 without any activation agents. 
But our data certainly did not refute the importance of mast cell activation in adhesion. In 
fact, we found that FcɛRI aggregation augmented initial adhesion and supported 
proliferation on electrospun bioresorbable vascular graft materials. IgE binding to mast 
cells is referred to as a ‘passive presensitization’ step. In this study, IgE in the absence of 
antigen greatly augmented adhesion but did not support long-term survival and 
proliferation of mast cells in the absence of antigen. It is important to note that surface 
FcɛRI on mast cells are nearly saturated in vivo. It has been reported previously that more 
than 80% of mast cell surface FcɛRI are occupied by 7 weeks of age in mice [171]. 
Therefore, passive presensitization is likely to occur, and may have important effects on 
mast cell adhesion to grafted polymers. 
Xiang et al. showed that the survival effect of FcεRI aggregation occurs due to the    
expression of the anti-apoptotic Bcl-2-family protein A1. Mast-cell survival was abolished 
in A1a−/− mast cells, and the increase in the number of mast cells that is induced by FcεRI 
aggregation in vivo was not observed in A1a−/− mice [172]. In Figure 3, the decline in cell 
numbers by day 5 suggests that in the absence of antigen, continuous exposure to IgE is 
required for mast cell survival. In this study, IgE was not added to the culture medium that 
was used to feed the cells after day 1. It has been proposed that prolonged FcɛRI 
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aggregation is required for augmented proliferation of mast cells [173]. It has been shown 
that the binding of monomeric IgE to FcεRI does not induce DNA synthesis, but it renders 
mast cells resistant to apoptosis induced by growth factor deprivation. However, 
continuous presence of IgE is required for this anti-apoptotic effect [144]. It can therefore 
be concluded that the effects of IgE in the absence of antigen are short lived and are more 
prominent early on as compared to IgE+DNP, which has long-term effects on cells. 
It should be noted that the MTS assay cannot efficiently quantify cells that have 
migrated into the three-dimensional structure of the scaffold and only provides a reliable 
estimation of the cell number on the surface. The polymeric materials pose unique 
challenges via various mechanisms including diffusion gradients and sequestering effects. 
Efforts are underway to validate the modified diphenylamine assay for cell quantification, 
recently published for use with three-dimensional polymeric scaffolds [174]. 
The physical properties of silk and its ability to promote endothelial cell growth and 
proliferation make it a promising candidate for vascular tissue engineering scaffolds. 
However, this study found that silk scaffold with or without fibronectin treatment was not 
conducive for mast cell adhesion. Our results are consistent with a study conducted by 
Panilaitis et al. showing that silk was largely inert and even inhibitory with respect to 
murine macrophage activation [175].  
Tissue regeneration requires multiple cells and cytokines acting together in concert 
in a   proper sequence. Mast cells stimulated with IgE+DNP on PDO and PCL scaffolds as 
well as TCP produced high amounts of TNF-α, MIP-1α and IL-13. It has been demonstrated 
that mast cell derived TNF-α is a crucial component of host defense against bacterial 
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infection and is involved in recruitment of leukocytes by establishing cytokine networks 
[158, 159]. In healing wounds, MIP-1α plays a critical role in macrophage recruitment. It 
has been reported that MIP-1α levels increase during the inflammatory phase, and 
decrease as inflammation resolves and repair proceeds. It is essential for T-cell chemotaxis 
to inflamed tissue and also plays a critical role in the regulation of trans-endothelial 
migration of monocytes, dendritic cells, and natural killer cells [163-165]. 
IL-13 was also produced by mast cells adherent to the polymer scaffolds. IL-13 
induces expression of endothelial adhesion molecules such as vascular endothelial 
adhesion molecule-1 (VCAM-1) and chemokines which are required for recruitment of 
granulocytes and monocytes into tissues [176]. IL-13 stimulates macrophages and 
fibroblasts to synthesize collagen and promotes fibrosis by stimulating macrophages to 
produce transforming growth factor (TGF-β) [177]. These results demonstrate that mast 
cell cytokine synthesis can influence the biological response of various cell types that play 
an important part in tissue regeneration and angiogenesis. Improved knowledge of these 
mechanisms will allow us to control and modulate the reactions occurring at the 
host/implant interface.  
VEGF could only be produced from mast cells when they were cultured at very high 
densities. Mast cells were seeded at 23x106 cells/mL in a 48 well plate and stimulated with 
IgE (10 µg/mL) and DNP (100 ng/ml). Cell culture supernatants were collected after 24 
hours and the VEGF levels were quantified using ELISA. Both TCP and PDO produced 
similar levels of VEGF as shown in Figure 15. 
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Figure 15 Production of VEGF from murine mast cells on PDO and TCP. 
 
Although many of the differences between human and mouse mast cells appear 
quite subtle, caution must be observed when interpreting animal model research for use in 
clinical applications. Animal studies are important in assessing and screening for risks 
associated with the use of biomaterials in humans. They also help in determining the 
mechanisms of immune modulation and the cell types affected following biomaterial 
exposure [116, 178]. Evaluations that understand the behavior of mast cells on electrospun 
scaffolds at a molecular level may provide insight into the specific causes of effects 
observed in these studies. Such evaluations will help biomedical researchers in promoting 
biomaterial integration with the host tissue without any undesirable immune reactions. 
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II.6 Conclusion 
The present study examined for the first time the cytokine expression and adhesion 
of mast cells on bioresorbable electrospun scaffold for potential use as a vascular graft. The 
study demonstrates that biomaterial exposure can affect mast cell adhesion and cytokine 
expression. This indicates that mast cells might play a role in the process of biomaterial 
integration into the host, tissue regeneration, and possibly angiogenesis. Mast cell 
attachment onto fibronectin coated electrospun scaffolds led to survival and proliferation, 
and these cells retained their IgE-induced cytokine production. Improved knowledge of 
mast cell responses to biomaterials will allow a better understanding of the regeneration 
process and modulation of both acute and chronic inflammation of implanted biomaterials. 
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III.1 Abstract 
Macrophages (MΦ) are innate immune cells, crucial for tissue homeostasis, 
presentation of foreign and self-antigens following infection/injury, pathogen clearance, 
inflammation resolution, angiogenesis, and wound healing. MΦ display plasticity and can 
acquire pro-inflammatory (M1) or angiogenic/wound healing (M2) phenotypes depending 
upon the environmental stimuli. It has been well demonstrated in the literature that MΦ 
play a key role in determining the fate of any acellular prosthetic/scaffold. In this study, we 
analyzed how different properties of an electrospun scaffold impact the MΦ phenotype. 
Bone marrow derived murine macrophages (BMMΦs, 106 cells) were seeded on TCP 
(24 well plate) and PDO scaffolds (15 mm discs) electrospun from varying polymer 
concentrations (60, 100, and 140 mg/ml). Scaffold evaluation showed that large polymer 
concentrations led to larger fiber diameters, which in turn led to larger pore-sizes and 
porosity but a smaller surface area to volume ratio. After 24 hrs of culture, the cell lysates 
were analyzed for arginase (Arg1) and inducible nitric oxide synthase (iNOS) expression by 
western blot and cell culture supernatants were analyzed for nitric oxide (NO2-), tumor 
Necrosis Factor – alpha (TNF-α), interleukin-6 (IL-6), vascular endothelial growth factor 
(VEGF), transforming Growth Factor – beta1 (TGF-β1) and basic fibroblast growth factor 
(bFGF) levels.  
The results indicated a correlation between Arg1 expression and increasing 
fiber/pore-size, indicating that the larger fiber/pore-sizes polarize towards a M2 
phenotype. Also, the expression of iNOS was downregulated on the larger fiber/pore-size. 
The levels of NO2- were significantly higher on the lower fiber/pore-sizes indicating an M1 
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phenotype. The levels of VEGF, TGF-β1 and bFGF increased with increasing fiber/pore-
sizes. 
Therefore, in this study we have demonstrated that by varying the fiber diameter 
and the corresponding pore-size, we can modulate the macrophage phenotype. The study 
also shows that electrospun scaffolds of larger fiber/pore-size polarize BMMФs towards a 
M2 phenotype. 
III.2 Introduction 
Tissue engineered biomaterials often induce an inflammatory reaction, also known 
as the FBR after in vivo implantation. Upon exposure to implanted biomaterials MФs fuse 
into multinucleated giant cells called FBGCs and ultimately lead to fibrous encapsulation. 
However, the presence of MФ is also essential for early remodeling processes. The 
phenotypic profile of macrophages as M1 or M2 following exposure to the biomaterial can 
dictate the downstream processes of remodeling and angiogenesis. These processes are 
modulated via “cross-talk” between macrophages and other cells (e.g. endothelial cells) as 
well as factors within the local environment.  This study aims to gather insight into the 
macrophage activity on electrospun PDO by identifying the macrophage phenotype (M1 or 
M2). In general, M1s or classically activated MФs are pro-inflammatory and microbicidal, 
whereas M2s or alternatively activated MФs are immunomodulatory, reparative, and 
poorly microbicidal. The balance of these two phenotypes of MФs plays a critical role in the 
phagocytosis of pathogens and bacteria, the clearance of apoptotic cells, and the 
remodeling of injured tissues. These activation states of MФs are hypothetical ends of a 
spectrum. The actual MФ phenotype is viewed as a continuum of functional states.   
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Recently M2s were further divided into M2a, M2b and M2c based on their different 
roles in tissue remodeling. M2a phenotype arises in response to IL-4 and IL-13 and these 
MФ are associated with Th2 responses. The M2b phenotype is induced by immune 
complexes as well as agonists of TLRs or IL-1 receptors and these MФ secrete high amounts 
of IL-10 but reduced IL-12. M2c phenotype is induced by IL-10 or glucocorticoids and they 
produce elevated levels of IL-10 and TGF-β1 and is associated with immune suppression 
and remodeling [3, 13]. In contrast, INF-γ or TNF-α primed MФs are grouped as M1s. These 
MФs have decreased phagocytic capability and (FcγR)II expression. M1s secrete pro-
inflammatory cytokines, such as TNF-α, IL-1, IL-6, IL-12, and IL-23, possess anti-
proliferative functions and induce Th1 responses. In addition, M1s are also crucial in 
matrix destruction and tissue reorganization at injured tissues via the production of a 
variety of enzymes such as MMPs, collagenase, elastase and hyaluronidase. This allows M1s 
to quickly migrate through injured tissues to clear pathogens and debris [3]. Mosser et al. 
suggested a spectrum of MФ phenotypes and characterized MФ populations based on three 
fundamental homeostatic activities, including host defense, wound healing, and immune 
regulation. MФ are grouped into three primary phenotypes: classically activated MФ for 
microbicidal activity, wound-healing MФ for tissue repair, and regulatory MФ for anti-
inflammatory activity [12]. 
MФ phenotypes exhibit plasticity, meaning that a classically activated M1 can switch 
to an alternatively activated M2. Prolonged activation of M1s can lead to tissue injury. 
Therefore, after disinfecting and debriding the wound site, the M1s must switch over to 
M2s at later stages to facilitate proper tissue remodeling. In a recent study skin biopsies 
from human patients were obtained and gene expression was analyzed on early (Day 1-2) 
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and late stages (Day 4-8) of cutaneous wound healing. It was observed that the early stage 
included a mix of M1 and M2 markers (11 M1 genes and 7 M2 genes) whereas the late 
stage expressed predominately M2 markers (1 M1 gene and 9 M2 genes) [17].  
Several biomaterial strategies have been used for the modulation of MФ phenotype. 
It has been shown that the biologic scaffold can profoundly affect the MФ phenotype. 
Uncrosslinked decellularized porcine small intestinal submucosa (SIS) induced a M2 
response (CD163+) and showed constructive tissue remodeling after 16 weeks in a rat 
model. Whereas, a carbodiimide crosslinked CuffPatch device elicited a M1 response 
(CD80+ and CCR7+) leading to chronic inflammation [179]. In another study, it was found 
that acellular ECM scaffolds induced a predominately M2 phenotype but cellular ECM 
scaffolds supported a M1 phenotype [111].   
MФ response to biomaterials is also dependent on their size. It has been shown that 
when foreign materials are < 10 µm, MФ can effectively phagocytose them. The process of 
phagocytosis leads to the formation of membrane bound phagosomes in the cytoplasm. The 
phagosomes fuse with endosomes and lysosomes to form phagolysosomes, which contain 
proteolytic and microbicidal substances to kill, digest and degrade the internalized 
particles. On encountering larger foreign materials (10-100 µm) that cannot be engulfed by 
a single MФ, mutltinucleated MФs or FBGCs are formed by the fusion of multiple MФs. 
These FBGCs then phagocytose and digest the foreign materials. When FBGCs encounter 
bulk materials that even they cannot effectively engulf, they undergo a process called 
“frustrated phagocytosis”. In this process MФs release an array of substances such as 
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cytokines, reactive oxygen species and proteolytic enzymes in an attempt to degrade the 
implanted materials [1].  
The impact of fiber diameter on MФ activation and response has been extensively 
studied. In a recent study, MФ (RAW 264.7 cell line) were cultured on electrospun poly(L-
lactic) (PLLA) scaffolds. The impact of substrate topography of PLLA scaffold on MФs was 
studied by comparing a PLLA film to electrospun aligned microfibers, aligned nanofibers, 
random microfibers, and random microfibers. The results showed that nanofibrous PLLA 
scaffolds (fiber diameter ~ 0.6 µm) minimized the inflammatory response when compared 
to films and microfibrous (fiber diameter ~ 1.6 µm) scaffolds. Histological evaluation 
demonstrated a higher number of FBGCs on the PLLA film than on the micro- and 
nanofibrous scaffolds. The fiber alignment didn’t seem to have an effect on the in vitro MФ 
activation and secretion of proinflammatory molecules [180]. In another study, single 
polypropylene fibers of diameters ranging from 2.1 to 26.7 µm were implanted in the 
subcutaneous dorsum of Sprague-Dawley rats. Results at 5 weeks showed reduced MФ 
density and fibrous capsule thickness for small diameter fibers in the range of 2.1 to 6 µm 
[181].  
The influence of pore-size on the MФ response has also been explored in several 
studies. Results have shown that pore dimensions of at least 10 µm are needed to allow 
connective tissue ingrowth and to avoid global tissue encapsulation [182]. In another study 
it was shown that a pore size range of 0.8-8.0 µm can facilitate neo-vascularization 80-100 
fold compared to samples with pores 0.1-0.8 µm or between 8-15 µm [101]. Dr. Ratner and 
co-workers fabricated poly (2-hydroxyethyl methacrylate-co-methacrylic acid) (pHEMA-
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co-MAA) hydrogel scaffolds with parallel channels by polymer fiber templating. The cardiac 
implantation of these hydrogels with pore diameters of 30-40 µm showed maximum 
vascularization and minimal fibrotic response and an increase in the number of M2 
phenotype MФs [183].  
In this study, bone marrow derived primary MФs (BMMФ) have been used instead 
of commercially available cell lines (RAW 264.7, J774A.1 or IC-21). This was done because 
the MФ cell lines are not equivalent in maturity or activation potential to primary MФs. A 
study done by Chamberlain et al. showed that cytokine expression at the protein level 
varied greatly between primary MФs and immortalized cell lines, with primary MФs 
initiating stronger and more diverse responses than the cell lines [184]. 
III.3 Materials and Methods 
III.3.1 Electrospinning of PDO Polymer  
  PDO (Ethicon Inc.) was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (TCI 
America) in concentrations of 60, 100 and 140 mg/ml. These solutions were then 
loaded into a Becton Dickinson syringe (5.0 ml) with an 18 gauge blunt tip needle and 
placed in a KD scientific syringe pump to be dispensed at a rate of 6 ml/hr. Solutions 
were then electrospun onto a flat rotating stainless steel mandrel (2.5 cm wide × 10.2 
cm long × 0.3 cm thick) to produce a flat sheet. All electrospinning was performed at an 
applied voltage of 23 kV, while the mandrel was rotated at a rate of 500 rpm and placed 
12 cm away from the needle tip. The fiber diameter of the electrospun scaffold was 
measured by Image J. The pore-size, porosity and surface area to volume ratio of the 
scaffolds was measured using a method described by Soliman et al. [102]. Briefly, 10 
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mm disks of the electrospun  scaffolds were weighed and subsequently immersed in 
ethanol overnight with slight mechanical agitation. This was done to allow the ethanol 
to penetrate into the scaffold pores. The surface of the samples was then blotted dry on 
a filter paper and weighed once more to determine the mass of the ethanol present 
within the scaffold. Measurements were made on five sample disks of each scaffold type. 
The density of ethanol is 0.789 g/mL and the density of PDO is 1.34 g/mL.  
The porosity (ε) was calculated as: 
ε = 
VETH
 VETH + VPDO
 
 VETH is the volume of the intruded ethanol and was calculated as the ratio 
between the observed mass change after intrusion and ρETH. VPDO is the volume of PDO 
fibers and was calculated as the ratio between the dry scaffold mass before intrusion 
and the density of PDO (ρPDO). The pore-radius was calculated from the following 
equation: 
   
 
  (
 
 )
 
where ω is the fiber diameter and ε is the scaffold porosity.  The surface area to 
volume ratio of the scaffolds was calculated using the formulas given by Boland et al. 
[137]. 
Surface area to volume ratio =
2* *rf*L
VPDO
 
L=
MPDO
ρPDO* *r2
 
   where L is the equivalent fiber length, rf  is the average fiber radius. 
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III.3.2 Endotoxin Content 
The endotoxin content of the electrospun polydioxanone (PDO) was determined by 
the Limulus Amebocyte Lysate (LAL) kinetic chromogenic assay (Endochrome-K™, Charles 
River) following manufacturer’s protocol. Briefly, 6 mm disks of PDO were incubated in 
endotoxin-free distilled water at 37⁰C for 24 h. Absorbed endotoxin was determined after 
incubation of the PDO disks in endotoxin-free distilled water at 37⁰C for 60 min with 
constant shaking. Afterwards, samples (water) were collected under sterile conditions and 
transferred to endotoxin-free tubes. Endotoxin levels were quantified using the LAL kinetic 
chromogenic assay at 450 nm [25].  
III.3.3 Macrophage Isolation and Cytokine Secretion 
Bone marrow derived murine macrophages (BMMΦs) interaction with electrospun 
PDO (100 mg/ml, 10 mm discs) and tissue culture plastic (TCP) was evaluated by seeding 
500,000 cells in a 48 well plate with or without lipopolysaccharide (LPS, Sigma-Aldrich 
L6529) (100 ng/ml). The supernatants were collected after 24 hrs to quantify pro-
inflammatory mediators (TNF-α, IL-6, Nitrite (N02 -)) and wound-healing mediators (VEGF, 
TGF-β1 and bFGF) by ELISA. The C57BL/6 mouse strain was used as a source of bone 
marrow.  Following standard protocol in Dr. Ryan’s lab, the mice were euthanized and the 
bone marrow was isolated from the femurs/tibias.  To deplete the adherent stromal cells, 
the harvested bone marrow was cultured overnight in complete RPMI (with 1% penicillin 
and streptomycin, L-glutamine, HEPES, sodium pyruvate, 10% FBS, and 30 ng/ml 
recombinant murine MФ-colony stimulating factor (rmM-CSF)).  Non-adherent cells were 
collected, red blood cells lysed, remaining non-adherent mononuclear cells plated, and 
cultured for 7 days in the presence of rmM-CSF.  Phenotype uniformity (naïve MФ (M0) vs. 
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monocytes) was verified by flow cytometry with our results showing this protocol to 
achieve a >96% MAC (CD68+) population. After maturation the BMMФ were divided into 
three different groups and stimulated for 48 hrs in the presence of either IL-4 and IL-13 to 
polarize BMMФ to a M2 phenotype or INF-γ to polarize the BMMФ to a M1 phenotype. The 
INF-γ treated BMMФ were then rinsed with media and treated with LPS for additional 18 
hrs. Untreated BMMФs were used as the naïve group (M0s). The morphology of polarized 
MФs on TCP is shown in Figure 16. Extensive pseudopodia were observed in M1s 
compared to M0s and M2s. In contrast, M2s appeared more rounded. Stimulation with IL-4 
and IL-13 produced a mild proliferative effect whereas, stimulation with INF-γ led to an 
apoptotic effect. 
 
 
Figure 16 BMMФ polarization into M1 and M2 phenotypes on TCP. 
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III.3.4  Arginase and iNOS Expression 
 BMMΦs (106 cells) were seeded on TCP (24 well plate) and PDO scaffolds (15 mm 
discs) made from varying polymer concentrations (60, 100, and 140 mg/ml). After 24 hrs, 
the cell lysates were analyzed for arginase (Arg1) and inducible nitric oxide synthase 
(iNOS) expression by western blot. Cell seeded scaffolds were picked up from the well plate 
and transferred to a micro-centrifuge tube. The scaffolds were rinsed with PBS and lysed 
on ice in 50 µl of lysis buffer consisting of 10mM Tris-Cl, 150mM NaCl, 1mM EDTA, 1% 
Triton X-100, 0.5% sodium dexoycholate, 1mM phenylmethyl sulphonylfluoride (PMSF) 
and complete protease inhibitor cocktail tablet. The extracts were vortexed vigorously for 
3 times at 5 min intervals. The lysates were collected and transferred to a fresh micro-
centrifuge tube. The lysates were centrifuged and the supernatants were obtained and 
stored at -20°C until needed. Protein concentration was determined by the Bradford 
method using BioRad’s protein assay reagent.  Protein lysates were completely denatured 
by boiling in Lammeli sample buffer for 10 mins and subjected to SDS-PAGE.  The proteins 
separated in the gel were transferred to a nitrocellulose membrane. The membrane was 
blocked with 5% nonfat dry milk in Tris –buffered saline containing 1% Tween 20 (TBST). 
The membrane was then washed four times with TBST and incubated in the primary 
antibody solution (containing 5% BSA) overnight at 4°C. The membrane was washed again 
four times in TBST and incubated in HRP-conjugated secondary IgG antibody-diluted 
solution (in 5% non-fat dry milk) for 1h at room temperature. After the membrane is 
thoroughly washed with TBST four times, chemiluminescense was detected using the ECL 
western blotting detection reagent. The antibodies used in this study are Arginase I 
(Abcam, ab91279, dilution 1:3000) and iNOS (Abcam, ab15323, dilution 1:2500). 
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III.3.4  Comparison of fiber diameter vs. pore-size in BMMФ phenotype modulation  
  In order to investigate which property of the PDO scaffolds plays a more 
important role in BMMФ phenotype modulation, the 60 mg/ml PDO scaffolds were 
made more porous and the 140 mg/ml PDO scaffolds were made less porous without 
significantly changing their fiber diameter. The 60 mg/ml PDO scaffold was made more 
porous using a method described by McClure et al., called air-flow impedance 
electrospinning. PDO (60 mg/ml) was loaded into a 3 mL plastic Becton Dickinson 
syringe with an 18 gauge tip needle and dispensed at a rate of 6 ml/h. The needle tip 
was subjected to +25kV with an air gap distance of 20 cm between the needle and the 
mandrel. Perforated mandrel contained 0.75 mm diameter holes laterally spaced 2.0 
mm center to center distance, while the center to center longitudnal distance was 1.50 
mm. The perforated mandrel was subjected to an air pressure of 100 kPa. On one end of 
the perforated mandrel, a lure lock was fitted and taped to the perforated mandrel 
using electrical tape. On the other end, a 3 mm diameter solid mandrel was inserted into 
the perforated mandrel and taped in place. The setup is depicted in Figure 17 [109].  
  The 140 mg/ml PDO scaffold was made less porous by compressing the scaffolds. 
Briefly, PDO scaffold of 140 mg/ml was cut into flat rectangular sheets carefully 
avoiding any raised edges. The sheets were then placed in between two flat stainless 
steel blocks.  This assembly was compressed to 5000 psi using a mechanical hydraulic 
press (Carver, Inc. Wabash, IN) and the pressure was held for one minute. This method 
of compression collapsed the pores in the scaffold. This led to a decrease in the pore -
size of the scaffold from 14 µm to 9 µm without severely impacting the fiber diameter.  
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Figure 17 (A) Perforated mandrel used for electrospinning, (B) mandrel set up with air line 
connected [109]. 
  BMMФs (106) were seeded on 12 mm disks of 60 mg/ml PDO scaffolds 
electrospun on solid and air-flow impedance impedance mandrels as well as on regular 
and compressed 140 mg/ml PDO scaffolds , in a 48 well plate. The BMMФs were seeded 
on these scaffolds as pre-polarized M2s as described previously. Cell culture lysates 
were collected after 24 hours and analyzed for Arg1 expression. 
 
III.3.5 Statistical Analysis 
Data expressed in this chapter is in the format of means ± standard deviation. Each 
experiment was done in triplicates and was reproduced at least twice. All statistical 
analysis of the data was based on a Kruskal-Wallis one-way analysis of variance on ranks 
and a Tukey-Kramer pairwise multiple comparison procedure (α=0.05) performed with 
JMP®IN 8 statistical software (SAS Institute). P<0.05 was considered significantly different. 
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III.4 Results 
Iii.4.1 Electrospun PDO Properties 
It was observed that by increasing the polymer concentration of PDO, electrospun 
scaffolds of varying properties are obtained (Figure 18). Increasing the polymer 
concentration led to a linear increase in the fiber diameters, pore-sizes and porosity but 
decreased the surface area to volume ratio. The statistical differences were only observed 
in the case of 60 mg/ml and 140 mg/ml scaffolds.  The properties of 100 mg/ml and 140 
mg/ml scaffolds were not statistically different from one another. It was also noted that the 
60 mg/ml scaffold showed beaded fibers but this was not observed with 100 and 140 
mg/ml scaffolds that showed smooth continuous fibers. It should also be noted that above 
140 mg/ml, the polymer solution becomes too viscous and the scaffolds cannot be 
reproducibly electrospun leading to inconsistency in data.  
 
 
 
 
 
 
 
 
 
 
60 mg/ml 100 mg/ml 140 mg/ml 
 
 
 
 
 
Concentration 
(mg/ml) 
Pore 
Radius  
(μm) 
Fiber 
Diameter 
(μm) 
Surface 
Area to 
Volume 
Ratio 
(m2/cm3) 
Porosity 
 (%) 
60  
 
0.96 ± 0.09 0.35 ± 0.2 11.4 69.4 ± 2.33 
100  10.57 ± 0.72 2.2 ± 0.1 1.8 81.16 ± 1.13 
140 14.73 ± 0.62 2.8 ± 0.5 1.4 82.67 ± 0.703 
Figure 18 Properties of PDO scaffolds electrospun from different concentrations. 
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III.4.2 Endotoxin Content 
Before proceeding with any experiments, we made sure that our PDO scaffolds were 
not contaminated with bacteria. Since the most common source of bacterial contamination 
is endotoxin, we determined its levels in our scaffolds. The values for endotoxin content 
ranged from 0.03 – 0.09 EU/ml. Therefore, the highest endotoxin level for any scaffold was 
at least 12,000 times lower than the lowest amount used to activate BMMΦs (100 ng/ml of 
LPS corresponding to 1100 EU/ml) and well below the acceptable U.S. Pharmacopeia 
standard for clinical applications (<0.25 EU/ml). This study indicated that the PDO 
materials used in this study were endotoxin free.  
III.4.3 Histological Evaluation 
The histological evaluation (H&E staining) of PDO scaffolds showed greater BMMФ 
(M0s and M2s) infiltration into the fibrous structures of larger fiber/pore-size scaffold 
(Figure 19). BMMФ infiltration was quantified using Image J. As expected, the results 
showed that with increasing fiber/pore-sizes, BMMФ infiltration of the scaffold cross-
sectional area for M0s and M2s increased linearly. The M0s and M2s in the case of small 
fiber/pore-size PDO (60 mg/ml) scaffold were found concentrated at the surface. The 
BMMФ infiltration was statistically higher in the large fiber/pore-size scaffold (140 mg/ml) 
when compared to the 60 mg/ml scaffold. However, an unexpected result was observed in 
BMMФ of the M1 phenotype. In the case of M1s, greater infiltration was observed on the 60 
mg/ml. This observation might be attributed to the release of MMPs and other matrix 
degrading proteolytic enzymes (such as collagenase, elastase and hylauronidase) secreted 
by the M1 phenotype macrophages [3]. It is known that M1s make their way into tissue by 
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degrading and destroying it in an attempt to clear the tissue of pathogens and debris. 
Therefore, prolonged activation of M1s in the absence of M2s leads to tissue injury. 
III.4.4 Arginase and iNOS Expression 
The results indicated a correlation between Arg1 expression and increasing 
fiber/pore-sizes in all BMMФ groups (M0, M1 and M2) on Day 1 (Figure 20). The 
expression of iNOS decreased with increasing fiber/pore-sizes. Three pieces of data emerge 
from these results: (1) These results indicate that the larger fiber/pore-sizes (140 mg/ml 
PDO scaffold, 14 µm pore-size) polarize towards an M2 phenotype in naïve BMMФ (M0s). 
(2) The larger fiber/pore-sizes are able to induce statistically higher Arg1 expression and 
downregulate iNOS in M1 pre-polarized BMMФ (3) The pre-polarized M2 BMMФs induce 
statistically higher Arg1 expression on the large fiber/pore-sizes on Day 1.  
On Day 3, it was observed that M0s were unable to maintain Arg1 expression 
(Figure 21). However, M1 and M2s were able to maintain Arg1 expression. Just like day 1, 
the larger fiber/pore-sizes induced statistically higher Arg1 by M1s on Day 3 as well. The 
Arg1 expression level by M2s was maintained on the large fiber/pore-size. It was also 
observed that the M2s on the small fiber/pore-size PDO increased their Arg1 production on 
Day 3 compared to Day 1. The expression of iNOS was totally abolished by Day 3 on all 
fiber/pore-sizes of PDO. In the previous study, we have demonstrated that larger 
fiber/pore-sizes allow increased M0 and M2 phenotype BMMΦ infiltration of the scaffold, 
when compared to smaller fiber/pore-sizes.  
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Figure 19 Histological evaluation of BMMФ infiltration into the fibrous structures of PDO. 
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Figure 20 Arginase and iNOS expression by BMMФs on Day 1. 
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Figure 21 Arginase and iNOS Expression Analysis on Day 3. 
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Additionally, the ease of migration through the bigger pore-size material combined 
with their orientation in the 3D space of the scaffold nanostructure may have a role to play 
in the observed shift of BMMФ towards a M2 phenotype. In contrast, the BMMФ in case of 
the 100 mg/ml scaffold are spatially confined. In case of the 60 mg/ml scaffold, the BMMФ 
are concentrated at the surface likely undergoing frustrated phagocytosis. This may have a 
role to play in pushing the BMMФs towards a M1 phenotype on the 60 mg/ml and 100 
mg/ml scaffold. The M1s invade deeper into the 60 mg/ml scaffold but they probably do it 
by causing tissue injury through MMPs. This could be the reason why these M1s are unable 
to shift to an M2 phenotype. 
III.4.5 BMMΦ Mediator Secretion 
The production of cytokines and growth factors characteristic of both M1 and M2 
phenotypes were quantified on Day 1 and 3. The level of Nitrite (NO2-, M1 phenotype) 
production was measured by the Griess Assay (Promega). All ELISA kits were purchased 
from Peprotech except for bFGF (Abcam) and TGF-β1 (R&D systems). The levels of TNF-α, 
IL-6 (indicative of M1 phenoype) and growth factors associated with the M2 phenotype 
(VEGF, bFGF, TGF-β1) were measured by ELISA. The levels of all cytokines and growth 
factors were normalized to the total protein content. The results showed that PDO is a 
potent activator of BMMΦs, characterized by the secretion of both pro-inflammatory (M1) 
and wound healing (M2) mediators.  
The production of Nitrite (NO2-) is shown in Figure 22. Nitrite is a product of 
Arginine metabolism by iNOS. The levels of nitrite are often used in the literature as a 
measure of iNOS activity. As seen in Figure 22, the highest levels of nitrite were produced 
by M1s on Day 1. The levels were found to be much lower on Day 3 compared to Day 1.  The 
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level of nitrite was downregulated in M1s cultured on the larger fiber/pore-size PDO on 
both Day 1 and Day 3.  
The levels of TNF-α are shown in Figure 23. The highest levels of TNF-α were 
produced from the M1 phenotype BMMФ (~ 300 times greater compared to M0s and M2s). 
The levels of TNF-α were not found to be significantly different between PDO scaffolds of 
different fiber/pore-sizes. The levels were decreased on Day 3 and trended lower on the 
140 mg/ml scaffold while still remaining statistically not significant compared to the 60 
mg/ml scaffold.  
The quantification of IL-6 cytokine is shown in Figure 24. The levels of IL-6 were 
also produced in highest quantities by M1 phenotype BMMФs. Just like TNF-α, the levels of 
IL-6 could not be downregulated by the large fiber/pore-size PDO. The levels remained 
fairly constant across different fiber/pore-sizes on both Day 1 and 3.  
The levels of VEGF by BMMФ are shown in Figure 25. Similar levels of VEGF were 
produced from M1 and M2 BMMФs and were found to be higher than M0s. In the case of 
M0s, the production of VEGF was significantly higher on the larger fiber/pore-size PDO. 
Continuing to look at M0s, it was observed that compared to Day 1, the level of VEGF on the 
60 mg/ml scaffold were much lower on Day 3 indicating that the 60 mg/ml scaffold is 
unable to maintain the expression of VEGF. In contrast, the level of VEGF on the 140 mg/ml 
scaffold increased on Day 3 compared to Day 1 indicating sustained expression of VEGF on 
the 140 mg/ml scaffold. In the case of M1s and M2s, no differences with respect to 
fiber/pore-sizes were noted.  
The cell culture supernatants were acid-activated as per manufacturer’s instructions 
prior to the TGF-β1 ELISA. Comparable levels of TGF-β1 were produced by all three BMMФ 
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phenotypes; M0s, M1s and M2s. The TGF-β1 expression was maintained until Day 3. The 
levels of TGF-β1 increased with increasing fiber/pore-sizes in M0s, M1s and M2s. The 
production of TGF-β1 was statistically higher on the 140 mg/ml scaffold compared to the 
60 mg/ml scaffold on Day 1 in the case of M0s and on both Day 1 and 3 in the case of M1s 
and M2s.  
The quantification of bFGF is shown in Figure 27. Just like the two other angiogenic 
growth factors (VEGF and TGF-β1), bFGF was also produced in comparable amounts by 
BMMФ of all three phenotypes; M0s, M1s and M2s. The production of bFGF was statistically 
higher on the 140 mg/ml scaffold compared to the 60 mg/ml scaffold on Day 1 in the case 
of M0s and M1s and on Day 3 in the case of M2s.  
The expression of two chemokines: Macrophage inflammatory factor -1 alpha (MIP-
1α) (Figure 28) and Macrophage chemotactic protein (MCP-1) (Figure 29) was also 
analyzed by ELISA. The levels of MIP-1α were much higher in M0s compared to M1s and 
M2s. The production of MIP-1α was statistically higher on the larger fiber/pore-size 
scaffold (140 mg/ml) compared to the 60 mg/ml scaffold in the case of M0s, M1s and M2s. 
The levels of MCP-1 were statistically higher on the 140 mg/ml PDO scaffold compared to 
the 60 mg/ml scaffold in the case of M1s on Day 1. 
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Figure 22 Expression of Nitrite by BMMФs indicating an M1 phenotype. The asterisk ‘*’ 
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold. 
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Figure 23 Expression of TNF-alpha by BMMФs indicating a M1 phenotype.  
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Figure 24 Production of IL-6 by macrophages. The asterisk ‘*’ indicates a statistical 
difference between the 60 mg/ml and the 140 mg/ml scaffold. 
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Figure 25 Expression of VEGF by BMMФs indicating a M2 phenotype. The asterisk ‘*’ 
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold. 
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Figure 26 Production of TGF-beta1 by BMMФs indicating a M2 phenotype. The asterisk ‘*’ 
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold. 
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Figure 27 Expression of bFGF by BMMФs indicating a M2 phenotype. The asterisk ‘*’ 
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold. 
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Figure 28 Production of MIP-1alpha by BMMФs indicating either a M1 or M2 phenotype. 
The asterisk ‘*’ indicates a statistical difference between the 60 mg/ml and the 140 mg/ml 
scaffold. 
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Figure 29 Production of MCP-1 by BMMФs indicating either a M1 or M2 phenotype. The 
asterisk ‘*’ indicates a statistical difference between the 60 mg/ml and the 140 mg/ml 
scaffold. 
 
 
87 
 
III.4.6 Comparison of fiber diameter vs. pore-size in BMMФ phenotype modulation 
During the electrospinning process, as fibers are deposited onto the perforated 
mandrel, pressurized air emanating from the mandrel perforations is introduced into the 
developing fibrous structure causing the fibers near the mandrel perforations to be less 
dense, creating regions of increased scaffold porosity.  In contrast, fibers deposited on 
solid, non-perforated sections of the mandrel (e.g. located between and adjacent to the 
perforations) are, in comparison, densely packed. The scaffold thus contains regions in 
which the fibers are porous and regions in which the fibers are densely packed, all within a 
single contiguous, seamless structure prepared during a single deposition event, thus not 
requiring multiple deposition steps and/or processing steps [109]. The properties of 
scaffolds created on solid vs. perforated mandrels are shown in Figure 30. The air-flow 
impedance method created a statistically significant increase in the pore-size and porosity 
of the scaffold but did not impact the fiber-diameter and the surface area to volume ratio. 
BMMФ were seeded on the 60 mg/ml PDO scaffolds (12 mm disks) created by 
traditional and air-flow impedance electrospinning methods at a density of 106 cells/well 
in a 48 well plate as pre-polarized M2s as described previously. The cell lysates were 
collected after 24 hours and analyzed by western blot for Arg1 expression. The analysis is 
shown in Figure 31. Compared to the solid mandrel, the air flow mandrel showed higher 
expression of Arg1 on M2s. The result corroborates our theory that bigger pore-size leads 
to a M2 phenotype.  
The 140 mg/ml PDO scaffold that was compressed had a pore-size of 9 µm 
compared to the normal 140 mg/ml PDO scaffold, which had a pore-size of 14 µm. The 
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overall porosity of the compressed scaffold also decreased significantly. The method of 
compression did not fuse the fibers but did flatten them out to some extent. This led to a 
slight increase in the overall fiber diameter as shown in Figure 32. The Arg1 expression by 
M2s was reduced on the compressed 140 mg/ml scaffold compared to the normal 140 
mg/ml scaffold. This result shows that pore-size is a more crucial regulator of Arg1 
expression. However, since the results were not significantly different from each other, it 
might indicate a role for the fiber-diameter in the modulation of Arg1 expression as well. 
 
 
Figure 30 Comparison of 60 mg/ml PDO scaffolds electrospun on the solid vs. air flow 
impedance mandrel. The asterisk ‘*’ indicates a statistical difference between the 60 mg/ml 
and the 140 mg/ml scaffold. 
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Figure 31 Arginase expression by M2s on 60 mg/ml scaffold electrospun on solid vs. air 
flow impedance mandrel. The asterisk ‘*’ indicates a statistical difference between the 60 
mg/ml and the 140 mg/ml scaffold. 
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Figure 32 Comparison of Normal vs. Compressed 140 mg/ml PDO scaffold. The asterisk ‘*’ 
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold. 
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Figure 33 Expression of Arg1 by M2s on normal and compressed 140 mg/ml PDO scaffolds. 
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III.5 Discussion 
The present study examined the effects of fiber/pore-size of a scaffold on MФ 
polarization. The study also examined the relationship between MФ polarization. The 
results of this study demonstrate that increase in the fiber/pore-size shifts the MФ 
phenotype to a more M2, tissue regenerative phenotype in vitro. This shift to an M2 
phenotype has been demonstrated in this study by increased Arg1, TGF-β1, VEGF, bFGF 
expression and decreased iNOS and N02- expression. 
The activation states of MФ are hypothetical ends of a spectrum. The actual MФ 
phenotype is viewed as a continuum of functional states. In the literature M2s have been 
classified into 3 main groups: M2a, M2b and M2c. M2a phenotype is induced by IL-4 and IL-
13 and they produce high amounts of anti-inflammatory cytokines and enzymes such as 
Arg1, FIZZ1 and RELM-1α. The M2b phenotype is induced by immune complexes as well as 
agonists of TLRs or IL-1 receptors and these MФ secrete high amounts of IL-10 but reduced 
IL-12. M2c phenotype is induced by IL-10 or glucocorticoids and they produce elevated 
levels of IL-10 and TGF-β1. We wanted to select an M2 phenotype that can function most 
effectively at tissue remodelling and angiogenesis. The production of VEGF by BMMФ on 
TCP in response to IL-4 combined with IL-10 and IL-13 is shown in Figure 34. IL-4 was 
chosen as an M2 phenotype inducer because it is known to activate MФ to produce 
arginase, fibronectin and other matrix proteins such as βIG-H3 and facilitates tissue 
remodelling and organization. The highest amount of VEGF was produced by BMMФ after 
treatment with both IL-4 and IL-13. Th2 cytokines, IL-4 and IL-13 are structurally similar 
and share a functional signalling receptor chain. It has been shown in a previous study that 
VEGF enhances IL-13 expression in the airways, suggesting a positive feedback loop with 
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VEGF enhancing Th2 sensitization and inflammation and IL-13 subsequently enhancing 
VEGF production [185].  
The production of MCP-1 and MIP-1α was significantly higher by M0s on 140 mg/ml 
scaffold when compared to M1s and M2s. Whether these chemokines fall under the M1 or 
the M2 phenotype category is not clearly known in the literature. Several studies have 
associated MCP-1 with Th2 or M2 macrophage phenotype responses [17, 186, 187].  It has 
been shown by Varin et al. that IL-4 inhibits MCP-1 [188]. Whereas, Martinez and Gordon 
documented that IL-4 induces MCP-1 [9]. Several studies have also classified MIP-1α as 
pro-inflammatory [180, 189]. In another study it was documented that MIP-1α is involved 
in chemotaxis and recruitment of monocytes and leukocytes during the initial 
inflammatory response, followed by a transition towards pro-wound healing activity [190]. 
Mantovani et al. and Schutte et al. classified both MIP-1α and MCP-1 as indicators of M1 
macrophage phenotype [13, 191]. It has been shown that MCP-1 recruits fibroblasts, MФs, 
endothelial cells and smooth muscle cells in vitro in cell migration assays and in vivo in 
murine carotid aneurysms. The same study also showed that MCP-1 mediated vascular 
inflammatory repair occurs via a MIP-1α and MIP-2 dependent pathway. Blocking MIP-1α 
and MIP-2 caused a significant decrease in MCP-1 mediated intra-aneurysmal tissue 
healing [192]. It has also been shown that MCP-1 can stimulate IL-4 production and MCP-1 
deficient mice are unable to mount Th2 responses [186]. There is also evidence for an 
essential pathogenic and inflammatory role for MCP-1, in which it is required for the 
accumulation of MФ. In another study, wound healing in MIP-1α and MCP-1 knockout mice 
was examined. It was found that wound re-epithelialization, angiogenesis and collagen 
synthesis in MIP-1α deficient mice was nearly identical to the WT controls. In contrast, 
94 
 
MCP-1 deficient mice displayed significantly delayed wound re-epithelialization, 
angiogenesis and collagen synthesis. Surprisingly, no change in the number of wound MФ 
was observed in the MCP-1 deficient mice, suggesting that monocyte recruitment into the 
wounds is independent of this chemokine [164]. In the light of this evidence, we would 
classify these chemokines at the cross-roads between M1s and M2s.  
The morphology of naïve (M0) and polarized MФs (M1 and M2) on electrospun PDO 
(100 mg/ml) is shown in Figure 35. It was observed that both M0s and M2s were spread 
out and interacting with fibers. In contrast to M0s and M2s, that had acquired a flattened 
shape on the scaffold, the M1s assumed a more rounded morphology. This rounded 
morphology could be due to the propensity for M1s to invade the matrix to destroy 
pathogens and debris. The rounded morphology probably enables them to squeeze through 
the pores in the scaffold and migrate into its structure.  
 
Figure 34 Production of VEGF from M2/Th2 associated cytokines. The asterisk ‘*’ indicates 
a statistical difference. 
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There were several limitations in the present study. A limited number of cytokines 
and surface markers were utilized for the characterization of the M1/M2 profile of the 
BMMФ. It is also recognized that species variations do exist. The markers chosen in this 
study (iNOS and Arg1) have been widely used as markers of M1 and M2 polarization in 
several studies. Care must be taken when extrapolating these studies to human MФs. In 
contrast to murine MФs, which can simply be identified by their ability to produce NO, 
human monocyte-derived MФs do not generate NO in response to classical activating 
stimuli. Therefore, human MФs must be identified by other criteria, including the 
upregulation of surface molecules such as major histocompatibility complex (MHC) Class II, 
co-stimulatory molecule CD86 and opsonic receptors [e.g., FcRIII (CD16)], enhanced ability 
to kill and degrade intracellular microorganism and the elevated capability to process and 
present antigens [3].  
The 60 mg/ml scaffolds and 140 mg/ml scaffolds differ remarkably in both pore-
size and fiber diameter. The results show that BMMФ are polarized towards a more M2-like 
phenotype on the 140 mg/ml scaffold. However, it is not known whether this result is 
because of the fiber diameter or the pore-size. To investigate this we made our 60 mg/ml 
scaffold more porous by electrospinning it using the air-flow impedance method. Using this 
method the fiber diameter stayed the same but the pore-size and the overall porosity of the 
scaffold improved. The results showed higher Arg1 expression in M2s on the 60 mg/ml 
scaffold created by the air-flow impedance method compared to the 60 mg/ml scaffold 
created on the solid mandrel created by traditional electrospinning. This result indicates 
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that pore-size might be playing a greater role compared to fiber diameter in BMMФ 
phenotype modulation.  
 
 
Figure 35 BMMФ morphology on electrospun PDO (100 mg/ml). (A) M0s (B) M1s (C) M2s 
(D) zoomed in view of a M2. 
 
The 140 mg/ml PDO scaffold was made less porous by compressing it using a 
hydraulic press. The Arg1 expression by M2s was reduced on the compressed 140 mg/ml 
scaffold compared to the normal 140 mg/ml scaffold. This result also showed that pore-
size is a more crucial regulator of Arg1 expression and BMMФ phenotype modulation.  
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III.6 Conclusion 
In this study we have demonstrated that by varying the fiber diameter and the 
corresponding pore-size, we can modulate the BMMФ phenotype. Electrospun PDO 
scaffolds of larger fiber/pore-sizes upregulated Arg1 expression and downregulated iNOS 
and nitrite expression in BMMФ.  In contrast, electrospun PDO scaffolds of smaller 
fiber/pore-sizes upregulated iNOS and nitrite expression but not Arg1. The production of 
angiogenic growth factors such as VEGF, TGF-β1 and bFGF from BMMФ was also greater on 
the larger fiber/pore-size PDO scaffolds. These results indicate that fiber/pore-size can 
influence the phenotype of BMMФ and that larger fiber/pore-size is capable of polarizing 
BMMФ towards a M2 phenotype. It was also observed that differences in fiber/pore-size of 
materials cannot modulate the expression of pro-inflammatory cytokines such as TNF-α 
and IL-6. The results showed higher Arg1 expression in M2s on the 60 mg/ml scaffold 
created by the air-flow impedance method compared to the 60 mg/ml scaffold created on 
the solid mandrel created by traditional electrospinning. The Arg1 expression was reduced 
on the compressed 140 mg/ml PDO scaffold compared to the normal 140 mg/ml scaffold. 
This result indicates that pore-size might be playing a greater role compared to fiber 
diameter in BMMФ phenotype modulation.  
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IV.1 Abstract 
In order to assess the angiogenic potential of BMMΦs cultured on PDO scaffolds, a 
previously described 3D angiogenesis bead assay was performed using conditioned media 
from the BMMΦ:PDO interaction [110]. Cytodex beads were coated with mouse endothelial 
cells and embedded in collagen gels in a 24 well plate. The supernatants from BMMФs (M0, 
M1 and M2) cultured on 12 mm disks on 60, 100 and 140 mg/ml PDO scaffolds were added 
on top of the collagen gels. The endothelial cells were allowed to form sprouts in the 
collagen gels for a period of 6 days. VEGF (20 ng/ml) was used as positive control in the 
study. The results of the 3D angiogenesis bead assay showed that the conditioned media 
from BMMФ of M0 and M2 phenotypes cultured on the bigger fiber/pore-size PDO scaffold 
(140 mg/ml) induced significantly larger average length of sprout. The conditioned media 
from BMMФ of M0, M1, and M2 phenotypes cultured on the bigger fiber/pore-size PDO 
scaffold induced significantly higher percentage density of sprouts. These results 
demonstrate that the M2 phenotype BMMФs cultured on the larger fiber/pore-size PDO 
scaffold are functional and are capable of supporting angiogenesis in the right 
microenvironment. The study further confirms that the naïve (M0s) and pre-polarized M1 
BMMФs behave like M2s in phenotype (shown by arginase and angiogenic growth factor 
expression in Chapter III) and function when cultured on the 140 mg/ml scaffold. 
IV.2 Introduction 
Angiogenesis is associated with degradation and reformation of the vascular 
basement membrane (VBM). In response to growth factors and matrix metalloproteinases 
(MMPs), the VBM undergoes degradative and structural changes. This transition from 
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mature VBM to provisional matrix promotes the proliferation and migration of vascular 
endothelial cells. Growth factors, such as vascular endothelial growth factor (VEGF), basic 
fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF), are released 
from the VBM, and are also produced by tumour cells, fibroblasts and immune cells. This 
induces formation of an intermediate, and then a new (mature) VBM. Endothelial cells 
assemble as solid cords that eventually acquire a lumen. Together with the vascular 
endothelial cells and pericytes, the VBM mediates formation of a new blood vessel [28].  
Endothelial cell differentiation (i.e. lumen or tube formation) can be studied in vitro 
both in two dimensions and in three dimensions. Endothelial cells cultured on plates 
coated with matrix proteins such as Matrigel (a matrix scaffold that incorporates 
extracellular matrix and basement membrane proteins), collagen, or fibrin can be induced 
to differentiate and lend themselves to a common model of in vitro angiogenesis [193]. 
However, it has been shown in several studies that in order to mimic the in vivo features of 
both cell morphological phenotype and gene expression profile,  3D culturing models 
should be used [194, 195].  In this angiogenesis study, we used a 3D collagen gel as a matrix 
to facilitate sprouting from endothelial cells. It has been shown in previous studies that 
matrix stiffness has an inverse relationship with angiogenesis. Less rigid matrices (such as 
fibrin or matrigel) promote better blood vessel formation in vitro compared to stiffer 
matrices such as collagen. We observed that plain cRPMI media with 10% FBS was capable 
of inducing sprouts from endothelial cell coated beads in a fibrin gel. This was not observed 
in the case of collagen gels. In order to avoid background issues with fibrin gels, we decided 
to pursue this assay with collagen gels. Also, the main aim of this study is to design a 
vascular graft. We are mainly interested in applying the understanding and control of 
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angiogenic processes to promoting vascular healing after arterial injury. Collagen is an 
abundant protein of the native blood vessel and so using collagen gels for this angiogenesis 
study is a better model for our overall aim of designing a vascular graft compared to fibrin 
[196-198]. 
IV.3 Materials and Methods 
IV.3.1 Three Dimensional (3D) Angiogenesis Assay 
  In order to assess the angiogenic potential of these M2 polarized BMMΦs, a 3D 
angiogenesis bead assay was performed following the method described by Chen et al. 
[110] using conditioned media from the non-stimulated BMMΦ:PDO interaction. The 
BMMФ were isolated from the bone marrow of C57BL/6 mice as described in chapter 
III. The BMMФ were seeded on 15 mm disks of PDO scaffolds electrospun at 60, 100 and 
140 mg/ml in a 24 well plate at a density of a 106 cells/ml. The cell culture supernatants 
were collected on Day 1 and 3. The dry Cytodex 3 microcarriers (Sigma Aldrich) were 
hydrated and autoclaved. Approximately 6 million mouse endothelial cells (ECs, ATCC) 
from a confluent T175 flask (passage 5) were mixed with Cytodex beads (~9000) in 25 
ml of Endothelial growth media (DMEM high glucose with 10% FBS, 1% P/S) media in a 
50 ml centrifuge tube. This mixture of EC and beads was incubated at 5% CO2 and 37°C 
for 4-5 hours. The centrifuge tube was agitated every 30 mins to avoid clumping of the 
bead-cell suspension and to ensure uniform coating. The mixture was then removed 
from the centrifuge tube and placed in a T-25 flask. The mixture in the T-25 flask was 
then incubated overnight to allow the cells that were not attached to the beads to attach 
to the flask. The next morning the beads were washed in Ca2+ and Mg2+ free PBS. The 
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media and the beads from the T-25 flask were transferred to a sterilized 50 ml 
centrifuge tube. The beads were then allowed to settle to the bottom of the centrifuge 
tube. As soon as the beads had settled, it was important to remove the medium quickly 
before the floating debris settled. After the medium was removed, 10 ml of Ca 2+ and 
Mg2+ free PBS was gently added into the centrifuge tube to repeat the wash procedure. 
A collagen solution was prepared by combining eight volumes of cold collagen type I (3 
mg/ml, Sigma-Aldrich) with one volume of 10x PBS and one volume of sodium 
hydroxide (0.1N). The EC coated beads were suspended in this collagen solution and 
added to a 24 well plate (500 µL/well). The plates were incubated at 37°C and 5% CO2 
for 15 min to allow collagen gel formation. The EC coated beads were cultured in 500 µL 
of either BMMФ: PDO conditioned media, EGM with 3% FBS (negative control) or EGM 
with 20 ng/ml VEGF (positive control).  
IV.3.2 Quantification of Angiogenesis 
  Each well containing the EC coated bead was digitally photographed under 
inverted microscopy at Day 6. A special grid (Figure 36) made by dividing a circle with 
radially oriented lines around 360 degrees with 10 degree intervals was used to 
quantify the percentage density of sprouts. This grid has been used in a previous study 
to quantify the migration of sprouts in the 3D matrix [199]. The digital photographs 
were transparently overlaid with the grid in Adobe Photoshop. The number of grid 
spaces with sprouts are counted and divided with the total number of grid spaces. The 
length of the sprout was calculated using the Image J software (NIH). The length of 
sprout was measured from the surface of the bead using the segmented line tool in the 
Image J software. A sprout was defined as a structure originating from the microcarrier 
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bead surface that was > 45 µm in length.  
 
Figure 36 Grid for quantification of angiogenesis (left) and diagram showing how the 
length of sprout was calculated. 
IV.3.3 Statistical Analysis 
Data expressed in this chapter is in the format of means ± standard deviation. Each 
experiment was done in triplicates and was reproduced at least twice. All statistical 
analysis of the data was based on a Kruskal-Wallis one-way analysis of variance on ranks 
and a Tukey-Kramer pairwise multiple comparison procedure (α=0.05) performed with 
JMP®IN 8 statistical software (SAS Institute).  
IV.4 Results 
The results of the 3D bead assay are shown in Figure 37. A representative image of 
each condition done in triplicate is shown. In all cases (M0s, M1s and M2s), the images 
showed greater sprouting from the conditioned media from BMMФ cultured on the larger 
fiber/pore-size PDO. Angiogenesis was measured by quantification of the average sprout 
length and the percentage density (Figure 38). The average sprout length induced by M0s 
on the larger fiber/pore-size (140 mg/ml) was statistically higher when compared to 
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smaller fiber/pore-sizes (100 mg/ml and 60 mg/ml PDO scaffolds). No sprouting was 
observed from the conditioned media of M0s cultured on the 60 mg/ml scaffold. The sprout 
length in the case of M0s cultured on the 140 mg/ml scaffold was statistically higher than 
all other samples tested except for the M2s cultured on the 140 mg/ml scaffold. This result 
shows that a naïve BMMФ (M0) cultured on the 140 mg/ml scaffold is as angiogenic as a 
pre-polarized M2. The sprout lengths induced by M1s were not different across different 
fiber/pore-sizes. In the case of M2s, the sprout length induced by the conditioned media 
from 140 mg/ml scaffold was statistically higher compared to the 60 mg/ml scaffold. 
Overall it was observed that M0s induced a ~200 fold higher and M2s induced a ~2 fold 
higher length of sprout from the 140 mg/ml compared to the 60 mg/ml PDO scaffolds. 
The quantification of the percentage density of sprouts is shown in Figure 34 
(bottom). It was observed that significantly higher density of sprouts was induced by 
BMMФs (M0s, M1s and M2s) cultured on the larger fiber/pore-sizes. Compared to the 60 
mg/ml scaffolds, the 140 mg/ml scaffolds induced a 94 fold higher density of sprouts from 
M0s, 7 fold higher density of sprouts from M1s and 17 fold higher density of sprouts from 
M2s. Therefore, these studies show that the larger fiber/pore-size PDO scaffold has greater 
potential for BMMФ mediated angiogenesis compared to the 60 mg/ml scaffold. 
The positive control used in this assay was 20 ng/ml VEGF. It should be noted that 
BMMФ conditioned media (especially in the case of 140 mg/ml scaffold) produced greater 
average length of sprouts and higher percentage density of sprouts compared to the 
positive control. This can be attributed to the fact that BMMФ conditioned media contains a 
lot of growth factors besides VEGF (such as TGF-β1 and bFGF) which also play very crucial 
roles in the process of angiogenesis. Therefore, it is not surprising that their combined 
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effects produced greater sprouting in terms of sprout length and density. The histograms 
for all the measurements of the sprout lengths are shown in Figure 39. These histograms 
were generated using MATLAB® R2011a. The dfittool of MATLAB® was used to fit a 
‘gamma’ distribution to the data.  It can be clearly seen that the 140 mg/ml has the highest 
sprout length across all the groups of BMMФ tested (i.e. M0, M1 and M2). 
IV.5 Conclusion 
 The assay showed the potential for PDO scaffolds to support MФ mediated 
angiogenesis. The conditioned media from BMMФ:PDO interaction was capable of inducing 
sprouts in the 3D angiogenesis assay.  It was observed that the BMMФ of M0, M1 and M2 
phenotypes cultured on the PDO scaffolds with bigger fiber/pore-size induced higher 
percentage density of sprouts. However, the conditioned media from BMMФ of only M0 
and M2 phenotypes cultured on the bigger fiber/pore-size PDO scaffold (140 mg/ml) 
induced significantly larger average length of sprout. Overall, the study confirms that the 
BMMФs of M2 phenotype are functional and support angiogenesis and that the naïve 
BMMФs acquire a functional M2-like phenotype when in contact with the bigger 
fiber/pore-size scaffold.  
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Figure 37 Sprouting from endothelial cell coated beads in response to conditioned media 
from BMMФ and PDO interaction (magnification 10x). 
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Figure 38 (Top) Quantified Average length of sprouts from the BMMФ conditioned media. 
(Bottom) Quantified Percentage density of sprouts from BMMФ conditioned media. 
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Figure 39 Density histograms of the measured sprout lengths. 
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V.1 Abstract 
 Toll-like receptors (TLRs) have been well recognized for their pivotal role in the 
detection of pathogen associated molecular patterns (PAMPs). Twelve TLRs, each detecting 
a distinct set of PAMPs, have been identified in mammals. TLR signaling is mostly MyD88 
dependent except for TLR3 signaling, which requires a TRIF adaptor. In the previous 
chapters, we have shown that BMMФs acquire different phenotypes on small vs. large 
fiber/pore-size materials. In this study we sought to investigate if they signal these 
responses via different mechanisms. We decided to assess TLR4 and MyD88 as potential 
candidates. BMMФs were isolated from TLR 4 and MyD88 knock-out mice and compared to 
BMMФs from WT mice.  BMMФs were cultured on 60 mg/ml and 140 mg/ml PDO scaffolds 
in three different conditions: M0s (naïve), M1 (classically activated) and M2 (alternatively 
activated). The Arginase and iNOS expression of WT and TLR4 or MyD88 knockout mice 
was compared by western blot. No significant differences between 60 mg/ml and 140 
mg/ml scaffolds were observed in the case of TLR4 deficient and WT BMMФs. However, 
severely impaired iNOS and Arginase expression was observed in the case of MyD88 
deficient M1 BMMФs on the 140 mg/ml scaffold.  This result indicates a potential role for 
MyD88 in regulating the signaling mechanisms for BMMФs of M1 phenotype on the large 
vs. small fiber/pore-size PDO scaffold. 
V.2 Introduction 
The mammalian TLRs are germline-encoded receptors expressed by the cells of the 
innate immune system. They recognize specific patterns of microbial components that are 
conserved among pathogens, but are not found in mammals. These patterns 
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characteristically expressed by bacteria, viruses and fungi are known as PAMPs. TLR 
interactions trigger the expression of proinflammatory cytokines as well as the functional 
maturation of antigen presenting cells of the innate immune system [21].  
TLR family consists of 12 members (TLR1-TLR12) and each TLR has been shown to 
recognize specific components of pathogens (Figure 40). TLR1–TLR7 and TLR9 have been 
characterized to recognize microbial components. TLR2 is essential for the recognition of 
microbial lipopeptides. TLR1 and TLR6 associate with TLR2, and discriminate subtle 
differences between triacyl- and diacyl lipopeptides, respectively. TLR4 recognizes LPS.  
TLR9 is the CpG DNA receptor, whereas TLR3 is implicated in the recognition of viral 
dsRNA.  TLR5 is a receptor for flagellin. Thus, the TLR family discriminates between 
specific patterns of microbial components. Different TLRs use different combinations of 
adaptor proteins to determine downstream signaling. The majority of TLR’s signal through 
an adapter protein called MyD88, which couples the TLR to downstream signaling kinases, 
eventually leading to the activation of NFκB by translocation from the cytoplasm to the 
nucleus. However, MyD88 independent signaling pathways do exist for TLR3 and TLR4.  
TLR4 possesses two options for signal transduction, either to signal through MyD88 or 
through TIR domain containing adapter inducing interferon-beta (TRIF), while TLR3 can 
signal only through TRIF [22].  
TLR4 is an important sensor for LPS. LPS stimulation of mammalian cells occurs 
through a series of interactions with several proteins including LPS binding protein (LBP), 
CD14, MD-2 and TLR4. LBP functions as a soluble shuttle protein that directly binds to LPS 
and facilitates its association between LPS and CD14. The transfer of LPS to the TLR4/MD-2 
receptor complex is facilitated by CD14. Upon LPS recognition, TLR4 undergoes 
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oligomerization and recruits TIR (toll-interleukin-1 receptor) domains. There are five TIR 
domain containing adaptor proteins: MyD88 (myeloid differentiation primary response 
gene 88), TIRAP (TIR domain containing adaptor protein, also known as Mal, MyD88-
adapter-like), TRIF (TIR domain-containing adaptor inducing IFN-β), TRAM (TRIF-related 
adaptor molecule) and SARM (sterile α and HEAT- Armadillo motifs-containing protein). 
TLR4 signaling has been divided into MyD88 dependent and MyD88-independent (TRIF-
dependent) pathways (Figure 41).  MyD88 contains a death domain (DD), which can recruit 
other DD-containing molecules through homotypic interactions. Upon LPS stimulation, 
MyD88 recruits and activates IL-1 receptor associated kinase 4 (IRAK-4). IRAK-4 is 
responsible for the subsequent recruitment, activation and degradation of IRAK-1. Another 
adaptor protein TRAF6 (TNF receptor associated factor 6), is critical for the MyD88 
dependent pathway downstream of IRAK4 and IRAK1. TRAF 6 activates TAK1 
(transforming growth factor-β-activated kinase 1). TAK1 then activates downstream IKK 
(inhibitor of κ light chain gene enhancer in B cells (IκB) kinase) and MAPK (mitogen-
activated protein kinase) pathways. IKK complex phosphorylates IκB proteins. This 
phosphorylation leads to the degradation of IκB proteins and subsequent translocation of 
the transcription factor NFκB, which controls the expression of proinflammatory cytokines, 
in addition to other immune related genes. The MyD88-dependent pathway can also 
activate p38 and c-Jun N-terminal kinase (JNK), leading to AP-1 activation followed by 
transcription of genes involved in regulation of cell proliferation, morphogenesis, 
apoptosis, and differentiation.  
TLR4 can also signal via a MyD88-independent pathway to stimulate the production 
of the antiviral protein interferon (IFN)-β. TLR4 can recruit another TIR-domain-
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containing adaptor called TRIF. Like MyD88, activated TRIF can bind to TRAF-6 to activate 
NFκB. Unlike MyD88, TRIF can also bind to kinases called IκKε and TBK1. These kinases 
activate transcription factors called IRFs (interferon regulatory factors) that are involved in 
stimulating IFN-β transcription. Thus, the adaptor TRIF enables TLR4 signaling to induce 
production of IFN-β in addition to activation of NFκB [23]. 
 
 
 
Figure 40 TLRs and their ligands [200]. 
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Figure 41 TLR4 Signaling pathways: MyD88 dependent and independent pathways [201]. 
 
V.3  Materials and Methods 
The involvement of TLR4 was studied by isolating BMMФ from the bone marrow of 
both Balb/c wild type and TLR4 knockout (KO) mice (Jackson Laboratories). To investigate 
the role of MyD88 in this phenotypic switch, BMMΦs were isolated from the bone marrow 
of both B6.129 wild type and MyD88 knockout (KO) mice (Jackson Laboratories). Following 
standard protocol in Dr. Ryan’s lab, the mice were euthanized and the bone marrow was 
isolated from the femurs/tibias.  To deplete the adherent stromal cells, the harvested bone 
marrow was cultured overnight in complete RPMI (with 1% penicillin and streptomycin, L-
glutamine, HEPES, sodium pyruvate, 10% FBS, and 30 ng/ml recombinant murine MФ-
colony stimulating factor (rmM-CSF)).  Non-adherent cells will be collected, red blood cells 
lysed, remaining non-adherent mononuclear cells plated, and cultured for 7 days in the 
115 
 
presence of rmM-CSF.  Phenotype uniformity (naïve MФ (M0) vs. monocytes) was verified 
by flow cytometry with our results showing this protocol to achieve a >96% MAC (CD68+) 
population. After maturation the BMMФ were divided into three different groups and 
stimulated for 48 hrs in the presence of either IL-4 and IL-13 to polarize BMMФ to a M2 
phenotype or INF-γ to polarize the BMMФ to a M1 phenotype. The INF-γ treated BMMФ 
were then rinsed with media and treated with LPS for additional 18 hrs. Untreated BMMФs 
were used as the naïve group (M0s). The BMMФ were cultured on PDO (106 /disc) and TCP 
for 24 hrs and their Arg1 and iNOS expression was analyzed by western blot. PDO scaffolds 
electrospun at 60 mg/ml and 140 mg/ml were used in this study since they showed 
markedly different induction of BMMФ phenotypes in the previous studies. Data expressed 
in this chapter is in the format of means ± standard error of mean. Each experiment was 
done in triplicates and was reproduced at least twice. All statistical analysis of the data was 
based on a Kruskal-Wallis one-way analysis of variance on ranks and a Tukey-Kramer 
pairwise multiple comparison procedure (α=0.05) performed with JMP®IN 8 statistical 
software (SAS Institute).  
V.4 Results 
In the absence of TLR4, no significant changes in iNOS or Arginase expression were 
observed in the case of large vs. small fiber/pore-size materials (Figure 42). This 
observation can be explained by the overlap and redundancy in function of the TLRs and 
also in their ability to elicit responses by forming receptor complexes with other TLRs. 
The MyD88 knockout and wild-type (WT) M0s and M2s expressed similar levels of 
Arg1 and iNOS. The only difference was observed in the case of M1s cultured on the 140 
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mg/ml scaffold (Figure 43). The MyD88 knockout M1s showed severely impaired ability to 
express both Arg1 and iNOS on the 140 mg/ml scaffold when compared to the WT M1s. No 
differences were observed in MyD88 knockout and WT M1s cultured on the 60 mg/ml 
scaffold. This indicates that scaffolds with large and small fiber/pore-sizes signal 
differently in the case of M1s. This result also shows that MyD88 is a key component 
involved in the BMMФ and 140 mg/ml scaffold interaction and signalling. It should also be 
noted that in this particular experiment we were unable to turn off iNOS with the larger 
fiber/pore-size scaffold. This could be due to the difference in the background of the mice 
used. It should be noted that both the MyD88 knockout and the WT mice were of the 
B6x129 background. 
In support of MyD88-dependent monocyte motility, Cote et al. [202] have 
demonstrated that in MyD88-/- mice exposed to the toxin 1-Methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), infiltration of monocytes/MФ to the CNS was significantly 
lower as compared with WT mice. In another study it has been shown that MФ isolated 
from MyD88 deficient mice did not migrate to hydrogen peroxide treated fibroblasts in a 
transwell model compared to the WT MФ [203]. Fibroblasts were treated with hydrogen 
peroxide to put them in a state of oxidative stress. The authors also showed that monocytes 
placed over stressed fibroblasts demonstrated a rounded shape with cells protruding into 
the pores in contrast to a more flattened morphology of control cells (i.e., placed over 
media or mock treated cells). In contrast, monocytes placed over stressed fibroblasts and 
treated with MyD88 inhibitory peptide acquired a more rounded shape. These data suggest 
that soluble factors released from oxidized cells can influence monocyte motility and can 
selectively attract them in a MyD88-dependent manner [203]. It has also been reported 
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that LPS-mediated Src induction led to increased FAK activation and cell migration in MФs, 
and which was iNOS-dependent [204]. We believe that autrocrine signals acting on M1 
phenotype BMMФs after LPS stimulation might be influencing their motility and migration 
capacity. We have shown in chapter III that BMMФ migration into the large pore 
electrospun scaffold (140 mg/ml) can influence and shift the phenotype of pre-polarized 
M1s to M2. Therefore, we believe that this impaired ability of MyD88 deficient BMMФ to 
migrate into the fibrous structure of 140 mg/ml scaffold leads to an impaired ability to turn 
into M2s (as demonstrated by decreased Arginase production).  
We have also observed that BMMФ from C57BL/6, B6x129 and Balb/c mice induce 
varying levels of Arg1 and iNOS expression in BMMФ. It is known that C57BL/6 mice are 
pro-Th1 whereas Balb/c and 129/Sv are pro-Th2. It has been reported that the outcome of 
myocardial infarct healing in mice strongly depends upon the genetic background. It was 
shown in that 129/Sv mice display an augmented inflammatory response after myocardial 
infarction compared with other mouse strains such as Balb/c or C57BL/6 [205]. It has also 
been documented that 129/Sv mice have high levels of circulating IgE and increased 
expression of IgE receptor (FcεRI) and greater sensitivity to anaphylaxis when compared to 
C57BL/6 mice [206]. These inherent differences in the genetic background of mice might 
explain the observed results. 
 
 
118 
 
V.5 Conclusion 
The result of this study indicates a potential role for MyD88 in regulating the 
signaling mechanisms for BMMФs of M1 phenotype on the large vs. small fiber/pore-size 
PDO scaffold. No significant differences between 60 mg/ml and 140 mg/ml scaffolds were 
observed in the case of TLR4 deficient and WT BMMФs. The redundancy in function of 
TLRs and also their ability to signal by forming receptor complexes with other TLRs could 
explain this result. On the other hand, severely impaired iNOS and Arginase expression was 
observed in the case of MyD88 deficient M1 BMMФs on the 140 mg/ml scaffold.  We 
believe that reduced mobility of MФs in the absence of MyD88 leads to impaired migration 
into the scaffold. This impaired migration doesn’t allow them to shift their phenotype to 
M2s (shown by impaired Arginase expression). 
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Figure 42 Involvement of TLR4 in BMMФ signaling. 
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Figure 43 Role of MyD88 in BMMФ signaling. The asterisk ‘*’ indicates a statistical 
difference between the WT and MyD88 KO BMMФ on the 140 mg/ml scaffold. 
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VI.1 Abstract 
Using the Directed in vivo angiogenesis assay (DIVAA), we have attempted to 
quantify in vivo angiogenesis and MФ phenotypes in response to PDO electrospun scaffolds 
(composed of small and large fiber/pore-size). This assay typically consists of 
subcutaneous implantation of semiclosed silicone cylinders (angioreactors) into nude mice. 
Angioreactors are filled with only 20 µl of Trevigen’s basement membrane extract (BME) 
premixed with or without angiogenic factors. Vascularization within angioreactors is 
quantified by the intravenous injection of fluorescein isothiocyanate (FITC)-dextran before 
their recovery, followed by spectrofluorimetry. This assay was modified to examine the 
angiogenic response of PDO. Tubes of 1 mm internal diameter were fabricated from 60 
mg/ml and 140 mg/ml concentrations and cut to length (9.2 mm) for insertion into the 
angioreactors. The PDO tubes were then filled with BME and implanted into the dorsal 
flanks of nude mice in quadruplicate. BME mixed with PBS was used as the negative control 
and BME mixed with VEGF/FGF-2 was used as the positive control in this assay. The results 
of spectrofluorimetry showed statistically higher signal intensity for the 140 mg/ml 
scaffold compared to the 60 mg/ml scaffold. However, problems of high background were 
observed in this assay with the use of materials such as PDO. We hypothesize that the 
reason for the observed high background is the formation of complexes between dextran 
and adsorbed plasma proteins on the surface of the PDO. More studies are needed to 
optimize this assay for use with biomaterials such as PDO. The PDO tubes (60 mg/ml and 
140 mg/ml) were also analyzed by H&E staining. The cross-sections of these tubes showed 
greater cell recruitment and infiltration into the fibrous structures of the 140 mg/ml tube 
compared to the 60 mg/ml tube.  This result is in agreement with the in vitro result of 
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BMMФ infiltrating deeper into the structures of the 140 mg/ml scaffold compared to the 60 
mg/ml scaffold. The scaffolds were also analyzed by immunostaining for iNOS (indicative of 
M1 phenotype of MФs). The results showed statistically higher ratios of iNOS 
positive:negative areas on the 60 mg/ml scaffold compared to the 140 mg/ml scaffold. 
Overall, these studies indicate that 140 mg/ml scaffold supports greater cell recruitment 
and cell infiltration in vivo but a smaller ratio of iNOS positive:negative areas compared to 
the 60 mg/ml scaffold, which supports a predominately M1 MФ phenotype. 
VI.2 Introduction 
 In vitro angiogenesis assays, based on endothelial cell cultures or tissue explants 
(e.g. aortic ring assays), focus on isolated endothelial cell functions such as proliferation, 
migration or invasion and fail to examine the coordination of cell functions required for a 
successful angiogenic response.  In contrast, in vivo angiogenesis assays examine the entire 
spectrum of molecular and cellular processes, with the endpoint being formation of new, 
functional blood vessels. Previous angiogenesis assays have been helpful in developing our 
understanding of the angiogenic process, but have been difficult to objectively quantify 
[207-209]. Trevigen’s directed in vivo angiogenesis assay (DIVAATM), is the first in vivo 
system for the study of angiogenesis that provides quantitative and reproducible results 
[210]. Typically in this assay, implant grade silicone cylinders closed at one end called 
angioreactors are filled with 20 µL of Trevigen’s basement membrane extract (BME) 
premixed with or without angiogenesis modulating factors. These angioreactors were then 
implanted subcutaneously in the dorsal flanks of nude mice. If the angioreactor is filled 
with angiogenic factors, vascular endothelial cells migrate into and proliferate in the BME 
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to form vessels in the angioreactor. This assay is a modification of the Matrigel plug assay. 
The main improvement is in the design of the angioreactor that prevents errors due to the 
absorption of the BME by the mouse. Additionally, the technique also allows material 
contained in the assay to be recovered for additional biochemical, cellular, genetic or 
histological testing. The BME used in this study is basically an extract of the basement 
membrane proteins from the murine Englebreth-Holm-Swarm tumor (also known as 
Matrigel). Due to the presence of low concentrations of endogenous growth factors in 
Matrigel alone, there have been reports of minimal angiogenic responses to Matrigel alone. 
VI.3 Materials and Methods 
VI.3.1 Quantification of DIVAA by Measuring FITC-Dextran Intensity 
Growth factor reduced BME (rBME) was thawed at 4⁰C, on ice, overnight prior to 
assay. rBME was kept on ice until gelling. Pipette tips, angioreactors, AngioRackTM, and 
angiogenesis modulating factors were all pre-chilled at 4⁰C, and rBME was kept on ice. 
Working on ice, angiogenic factors were added to one tube (200 μL) of rBME. Each tube of 
rBME (200 μl) was used to fill 8 angioreactors. FGF-2 (1.8 μg)/VEGF (600 ng) and 1 μl of 
heparin solution was added per 200 μL of rBME to be used as positive control 
angioreactors. Sterile PBS (11 μL) was added per 200 μL rBME to be used for the negative 
control angioreactors. The PDO tubes were fabricated on a 1 mm diameter mandrel (wall 
thickness = 300 µm) from 60 mg/ml and 140 mg/ml concentrations and cut to length (9.2 
mm) for insertion after ethanol disinfection and UV light sterilization (30 mins) into 
angioreactors. The dimensions of the angioreactor and the PDO tube are shown in Figure 
44. Angioreactors were kept chilled on ice prior to filling. rBME (20 μl) was added to each 
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angioreactor using an insulin syringe. Bubbles if any were eliminated by centrifuging 250 x 
g for 5 minutes at 4⁰C. The angioreactors were then subcutaneously implanted into the 
dorsal flanks of athymic nude mice. Four angioreactors, one of each condition (negative 
control, positive control, 60 mg/ml PDO tube, 140 mg/ml PDO tube) were implanted in 
each mouse, two on each side of the dorsal midline. Ten days after the implantation the 
angioreactors were harvested. Before collection of the angioreactors, mice received a 100 
µL injection of 25 mg/ml FITC-dextran in PBS via tail vein. The rBME from the tubes was 
removed and digested in 200µL of dispase solution for 3 hours at 37⁰C. After digestion the 
incubation mix was centrifuged and the fluorescence of the supernatant was measured in a 
96 well plate (excitation 485 nm, emission 510 nm). A diagram of the protocol is shown in 
Figure 45. 
VI.3.2 Histological Evaluation and Immunostaining 
The PDO tubes collected from the angioreactors were immediately fixed in 10% 
formalin for histological analysis. iNOS staining of the samples was done by 
immunohistochemistry-paraffin (IHC-P). The unstained sections of the samples on the 
slides were heated in 10 mM sodium citrate buffer (pH 6) at 95-100⁰C for 20 minutes. The 
heat was removed and the slides were incubated at room temperature in buffer for 20 
minutes. The slides were rinsed in Tris-buffered saline containing 0.05% tween-20 (TBST) 
for 1 minute. Blocking of the samples was done with 100 µl of 1% bovine serum albumin 
(BSA) for 20-30 minutes at room temperature. The blocking solution was drained from the 
slides. This was followed by staining with 100 µl of primary antibody (rabbit anti-mouse 
iNOS, Abcam 1:50) overnight at 4⁰C. The slides were washed 4 times in TBST for 5 minutes. 
A biotinylated goat anti-rabbit polyclonal antibody was used as the secondary antibody. A 
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100 µl of the secondary antibody diluted to 1:300 was used and the slides were incubated 
for 30 minutes at room temperature. The slides were washed again in TBST 4 times for 5 
minutes. A 100 μL DAB substrate solution (freshly made just before use: 0.05% DAB - 
0.015% H2O2 in PBS) was applied to the sections on the slides to reveal the color of the 
antibody staining. The color development was allowed to go on for 10-15 min until the 
desired color intensity was reached. The slides were washed in 300 ml PBS for 2 changes 5 
min each. The slides were counterstained by immersing the slides in Hematoxylin for 1-2 
mins. The slides were washed in running tap water for > 15 min. The slides were then 
dehydrate through 4 changes of alcohol (95%, 95%, 100% and 100%), 5 min each. The 
slides were cleared in 3 changes of xylene and coverslip using mounting solution. The exact 
same procedure was followed for the negative control slides except that they were not 
treated with the primary antibody. 
VI.3.3 Quantification of Histology 
 The quantification of immunohistological stains (brown or blue) in the samples 
were analyzed by MATLAB® R2011a. A code on the MathWorks website called “Color 
segmentation by Delta E color difference” was modified to be used in this study. In the code 
an RGB image is converted to LAB color space. The RGB color space defines a color as the 
percentages of red, green, and blue hues mixed together. The LAB color space is based on 
one channel for luminance (L) or brightness and two color channels; a and b. The a axis 
extends from green to red and the b axis from blue to yellow. After the image is converted 
into a LAB color space, the user draws a freehand irregularly shaped region to identify a 
color. The Delta E (the color difference in LAB color space) is then calculated for every pixel 
in the image between that pixel’s color and the average LAB color of the drawn region. The 
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user can then specify a number that says how close to that color would they like to be. The 
software will then find all pixels within that specified Delta E of the color of the drawn 
region. The extracted pixels of the matching colors are then displayed as “white” in a binary 
image. The number of non-zero (or white) pixels in the image are then counted and this 
value then serves as an intensity of the chosen color in the image. 
 
 
 
Figure 44 Dimensions of the (A) silicon angioreactor, (B) electrospun polymer tube, used in 
the study. 
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Figure 45 Diagram showing the protocol used for the modified DIVAA assay. 
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VI.3.4 Statistical Analysis 
Data expressed in this chapter is in the format of means ± standard deviation. Each 
experiment was done in triplicates and was reproduced at least twice. All statistical 
analysis of the data was based on a Kruskal-Wallis one-way analysis of variance on ranks 
and a Tukey-Kramer pairwise multiple comparison procedure (α=0.05) performed with 
JMP®IN 8 statistical software (SAS Institute).  
VI.4 Results 
VI.4.1 Quantification of DIVAA by Measuring FITC-Dextran Intensity 
Quantification of vascularization within the angioreactor is shown in Figure 46. 
Direct quantification of the angiogenic response is obtained by intravenous injection of 
FITC-dextran (average molecular weight, 150,000 Da) 20 mins prior to sacrificing the mice. 
Quantification of the fluorescence within the angioreactors reflects the internal vascular 
volume and is expected to correlate with the extent of angiogenic response. The results 
showed statistically higher signal intensity of FITC-dextran in case of the 140 mg/ml 
scaffold compared to all other conditions tested. Intravenous injection of the FITC-dextran 
is a measurement of blood volume within the angioreactor and is not necessarily a direct 
measure of the endothelial cell responses. Although the FITC-dextran signal intensity was 
greater in the positive control (containing FGF-2 and VEGF), the results showed only a 2 
fold increase between the positive control and the negative control (PBS). Previous reports 
of the DIVAA assay have also demonstrated high background associated with the assay 
[210].  FITC-dextran is functionally similar to tagged RBCs. Tagged RBCs give accurate 
blood volume determination because even in leaky capillaries RBCs due to their shape and 
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size rarely leak out in the intravascular space. Also, there have been reports of dextran 
interacting and forming complexes with plasma proteins such as fibrinogen. It is also 
known that when implanted in vivo, biomaterials acquire a layer of protein on their surface. 
It is possible that the higher signal observed in the case of PDO tubes compared to the 
positive control is because of the interaction between dextran and the layer of protein on 
the PDO surface.  The PDO tube electrospun at 140 mg/ml had statistically higher signal 
intensity for FITC-dextran compared to the 60 mg/ml PDO tube indicating greater 
angiogenesis on the 140 mg/ml scaffold. Due to the high background associated with the 
use of PDO material, this study must be confirmed by histological evaluation and CD31 
staining. Furthermore, this study was only performed once. More studies are required to 
optimize this assay for biomaterials such as PDO.   
VI.4.2 Histological Evaluation of PDO Tubes 
The PDO tubes (60 mg/ml and 140 mg/ml) were also analyzed by H&E staining. The 
results are shown in Figure 47. The cross-sections of these tubes showed greater cell 
recruitment and infiltration into the fibrous structures of the 140 mg/ml tube compared to 
the 60 mg/ml tube. Figure 47 shows the sections analyzed from different parts of the tube. 
The top panel shows the open part of the tube that had direct contact with the surrounding 
tissue. The bottom panel shows the bottom half of the tube that was at the closed end of the 
silicon angioreactor. The 60 mg/ml PDO tube shows cells concentrated at the surface of the 
scaffold and don’t migrate through the cross-section of the scaffold. In contrast, the 140 
mg/ml tube showed cells infiltrating through its fibrous structure. The number of cells at 
the open end of the tube were quantified by MATLAB ® R2011a using the previously 
described method.  The intensity of cells at the open end of the 140 mg/ml tube was 
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statistically higher compared to the 60 mg/ml tube. The quantification of cellular 
infiltration into the fibrous structures of the scaffolds was done using Image J. Analysis 
showed statistically greater depth of cellular infiltration through the cross-section of the 
140 mg/ml tube compared to the 60 mg/ml tube. This result is in agreement with the in 
vitro result of BMMФ infiltrating deeper into the structures of the 140 mg/ml scaffold 
compared to the 60 mg/ml scaffold. 
 
Figure 46 Evaluation of angiogenesis in DIVAATM angioreactors. The asterisk ‘*’ indicates a 
statistical difference between the 140 mg/ml scaffold and all other conditions tested. 
132 
 
 
Figure 47 (A) Histological evaluation of the cross section of PDO tubes harvested from the 
angioreactors after 10 days of implantation in vivo (magnification 20x). (B, C) 
Quantification of cellular infiltration into the scaffolds. The asterisk ‘*’ indicates a statistical 
difference between the 60 mg/ml and the 140 mg/ml scaffold. 
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VI.4.3 Immunostaining of PDO Tubes 
 The color segmentation method described in materials and methods was used for 
quantification. Briefly, each image was uploaded in MATLAB ® R2011a and the brown 
regions and blue regions were separated into two binary images as shown in Figure 48 and 
49. The total number of white pixels was counted in the 2 binary images. The ratio of these 
pixel counts then served as the intensity of iNOS positive (brown) vs. iNOS negative (blue) 
areas for each image. Immunostaining for iNOS showed a mixed population of iNOS 
positive (brown) and iNOS negative (blue) cells in the 140 mg/ml scaffold. In case of 60 
mg/ml scaffold majority of the recruited cells were stained positive for iNOS (Figure 50). 
Statistical analysis showed that 60 mg/ml scaffold had significantly higher ratio of iNOS 
positive: iNOS negative areas compared to the 140 mg/ml scaffold. Overall, this experiment 
demonstrated that the small fiber/pore-size scaffold (60 mg/ml) recruits less number of 
cells compared to the bigger fiber/pore-size (140 mg/ml) scaffold and the recruited cells 
on the 60 mg/ml scaffold are predominately of an M1 phenotype. Therefore, we have 
shown in a subcutaneous in vivo model that the 60 mg/ml scaffold supports the M1 
phenotype of MФ much strongly compared to the 140 mg/ml scaffold.  
 
 
 
 
134 
 
 
 
 
Figure 48 (A) Immunostained section of 60 mg/ml scaffold for iNOS (magnification 40x). 
(B) Binary image showing white pixels for all brown areas (positive for iNOS) in the 
original image. (C) Binary image showing white pixels for all blue areas (negative for iNOS) 
of the original image. 
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Figure 49 (A) Immunostained section of 140 mg/ml scaffold for iNOS (magnification 40x). 
(B) Binary image showing white pixels for all brown areas (positive for iNOS) in the 
original image. (C) Binary image showing white pixels for all blue areas (negative for iNOS) 
of the original image. 
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Figure 50 iNOS staining of histological samples of scaffolds from the in vivo study 
(magnification 40x). The asterisk ‘*’ indicates a statistical difference between the 60 mg/ml 
and the 140 mg/ml scaffold. 
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VI.5 Conclusion 
The DIVAA assay showed statistically higher FITC-dextran signal intensity for the 
140 mg/ml scaffold compared to the 60 mg/ml scaffold indicating greater angiogenic 
response in the 140 mg/ml tube.  However, problems of high background were observed in 
this assay with the use of electrospun PDO.  The observed high background was probably 
due to the formation of complexes between dextran and adsorbed plasma proteins on the 
surface of the PDO. More studies are needed to optimize this assay for use with 
biomaterials such as PDO. H&E staining of the harvested PDO tubes (60 mg/ml and 140 
mg/ml) was also performed. The cross-sections of these tubes showed greater cell 
recruitment and infiltration into the fibrous structures of the 140 mg/ml tube compared to 
the 60 mg/ml tube.  This result corroborates the in vitro result of BMMФ infiltrating deeper 
into the structures of the 140 mg/ml scaffold compared to the 60 mg/ml scaffold. The 
scaffolds were also analyzed by immunostaining for iNOS (indicative of M1 phenotype of 
MФs). The results showed statistically higher ratios of iNOS positive:negative areas on the 
60 mg/ml scaffold compared to the 140 mg/ml scaffold. Overall, these studies indicate that 
140 mg/ml scaffold supports greater cell recruitment and cell infiltration in vivo but a 
smaller ratio of iNOS positive:negative areas compared to the 60 mg/ml scaffold, which 
supports a predominately M1 MФ phenotype. 
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Chapter VII: Future Work and Concluding 
Remarks 
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VII.1  Summary  
MФ and mast cells are important cell types in the context of tissue remodeling and 
regeneration. Mast cells participate in the early stages of wound healing and modulate the 
acute inflammatory responses to biomaterials. Mast cells can secrete a myriad of different 
cytokines by the process of degranulation; the process of regulated secretion in which 
preformed contents stored in their granules are rapidly released by exocytosis. Some of 
these cytokines such as IL-4, IL-13 and TNF-α can modulate the MФ phenotype. 
In Chapter 2, the adhesion, proliferation and cytokine secretion of bone marrow 
derived murine mast cells (BMMC) on electrospun polydioxanone (PDO), polycaprolactone 
(PCL) and silk scaffolds, as well as tissue culture plastic (TCP) were investigated in the 
presence or absence of IL-3, SCF, IgE and IgE with a crosslinking antigen, dinitrophenol-
conjugated albumin (DNP). It was previously believed that only activated BMMCs exhibit 
adhesion and cytokine secretion. However, this study showed non-activated BMMC 
adhesion to electrospun scaffolds. Silk scaffold was not found to be conducive for mast cell 
adhesion and cytokine secretion. Activation by IgE and DNP significantly enhanced mast 
cell adhesion, proliferation, migration and secretion of TNF-α, MIP-1α and IL-13. This 
indicates that mast cells might play a role in MФ polarization, biomaterial integration into 
the host tissue, regeneration, and possibly angiogenesis. 
In the next study (Chapter 3) we have demonstrated that by varying the fiber 
diameter and the corresponding pore-size, we can modulate the macrophage phenotype. 
Electrospun PDO scaffolds of larger fiber/pore-sizes upregulated Arg1 expression and 
downregulated iNOS and nitrite expression in BMMФ. The production of angiogenic factors 
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such as VEGF, TGF-β1 and bFGF from BMMФ was also greater on the larger fiber/pore-
sizes. The expression of TNF-α and IL-6 could not be modulated by electrospun PDO of 
different fiber/pore-sizes.  
BMMФ mediated angiogenesis was examined using an in vitro bead assay in Chapter 
4. It was observed that the BMMФ of M0, M1 and M2 phenotypes cultured on the PDO 
scaffolds with bigger fiber/pore-size induced higher percentage density of sprouts. 
However, the conditioned media from BMMФ of only M0 and M2 phenotypes cultured on 
the bigger fiber/pore-size PDO scaffold (140 mg/ml) induced significantly larger average 
length of sprout. Overall, the study confirms that the BMMФs of M2 phenotype are 
functional and support angiogenesis and that the naïve BMMФs acquire a functional M2-
like phenotype when in contact with the bigger fiber/pore-size scaffold.  
The role for MyD88 and TLR4 in regulating the signaling mechanisms for BMMФs of 
M1/M2 phenotypes on the large vs. small fiber/pore-size PDO scaffolds was also 
investigated. This study is described in detail in Chapter 5. No significant differences 
between 60 mg/ml and 140 mg/ml scaffolds were observed in the case of TLR4 deficient 
and WT BMMФs. The redundancy in function of TLRs and also their ability to signal by 
forming receptor complexes with other TLRs could explain this result. On the other hand, 
severely impaired iNOS and Arginase expression was observed in the case of MyD88 
deficient M1 BMMФs on the 140 mg/ml scaffold.  We believe that reduced mobility of MФs 
in the absence of MyD88 leads to impaired migration into the scaffold. This impaired 
migration doesn’t allow them to shift their phenotype to M2s (shown by impaired Arg1 
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expression). Overall, this result indicates a potential role for fiber/pore-size in the signaling 
mechanism of BMMФ.  
A subcutaneous mouse model (described in Chapter 6) was used to evaluate the 
angiogenic and regenerative potential of PDO scaffolds in vivo. The DIVAA assay showed 
statistically higher FITC-dextran signal intensity for the 140 mg/ml scaffold compared to 
the 60 mg/ml scaffold indicating greater angiogenic response in the 140 mg/ml tube.  
However, problems of high background were observed in this assay with the use of 
electrospun PDO.  The observed high background was probably due to the formation of 
complexes between dextran and adsorbed plasma proteins on the surface of the PDO. More 
studies are needed to optimize this assay for use with biomaterials such as PDO. H&E 
staining of the harvested PDO tubes (60 mg/ml and 140 mg/ml) was also performed. The 
cross-sections of these tubes showed greater cell recruitment and infiltration into the 
fibrous structures of the 140 mg/ml tube compared to the 60 mg/ml tube.  This result 
corroborates the in vitro result of BMMФ infiltrating deeper into the structures of the 140 
mg/ml scaffold compared to the 60 mg/ml scaffold. The scaffolds were also analyzed by 
immunostaining for iNOS (indicative of M1 phenotype of MФs). The results showed 
statistically higher ratios of iNOS positive:negative areas on the 60 mg/ml scaffold 
compared to the 140 mg/ml scaffold. Overall, these studies indicate that 140 mg/ml 
scaffold supports greater cell recruitment and cell infiltration in vivo but a smaller ratio of 
iNOS positive:negative areas compared to the 60 mg/ml scaffold, which supports a 
predominately M1 MФ phenotype. 
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VII.2  Limitations and Future Studies 
There were several limitations in the present study. A limited number of MФ 
phenotype markers were used in this study. Although, iNOS and Arginase are widely 
accepted markers of M1 and M2 macrophages in a mouse model, care must be taken when 
extrapolating these studies to human MФs. Human M1/M2 phenotype MФs do not express 
iNOS or Arginase. Human MФs are identified by other criteria, including the upregulation of 
surface molecules such as major histocompatibility complex (MHC) Class II, co-stimulatory 
molecule CD86 and opsonic receptors [e.g., FcRIII (CD16)], enhanced ability to kill and 
degrade intracellular microorganism and the elevated capability to process and present 
antigens [3].  
In this dissertation, TCP is not exactly included in the studies as control but as a 
measure of the baseline activity of macrophages. We created films of PDO on 24 well plates. 
PDO films would have been the perfect 2D control for the 3D PDO scaffolds created by 
electrospinning. We could not successfully culture macrophages on films of PDO for 3 days. 
The macrophages did not survive on the PDO films past ~ 24 hours. 
Future studies would include investigation into the role of NFκB as a potential 
mediator in the signaling mechanism of small vs. large fiber/pore-size electrospun PDO. 
Since NFκB is the main downstream transcription factor of both MyD88 dependent and 
independent signaling mechanisms, and is the main regulatory factor of pro-inflammatory 
cytokines, it would be interesting to investigate the outcome of NFκB inhibition. If by 
inhibiting NFκB, we are able to suppress M1 phenotype on the electrospun PDO, strategies 
could be devised to incorporate NFκB inhibitor into the fibrous structures of PDO. A 
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scaffold that suppresses M1 phenotype responses could prove to be more angiogenic and 
regenerative when implanted in vivo. Care must be taken when studying BMMФ responses 
to NFκB activation inhibitor (Cat. No. 481406) from Calbiochem. This inhibitor is typically 
reconstituted in dimethyl sulfoxide (DMSO). I have found that BMMФ treatment with DMSO 
induces iNOS expression. Other studies have indicated that treatment with DMSO induces 
increased phagocytic ability in MФ. Alternatives to DMSO, such as ethanol can be explored 
to reconstitute the NFκB inhibitor. The siRNA technique could also be explored to look at 
the involvement of NFκB. 
To identify the particular TLRs involved in MФ interactions with electrospun 
scaffolds, double or triple knock out models of TLR2, 4 or 6 could be used. It has been 
shown that these TLRs mediate the dendritic cell interaction with biomaterials [25]. Since, 
DCs and BMMФ share many similarities in lineage and function; it is possible that TLR-2, 4 
and 6 might be involved in BMMФ signaling mechanisms as well. The involvement of TLR9 
can also be investigated by using siRNA technology. TLR9 could be involved since MФs are 
capable of degrading the electrospun scaffolds and internalize parts of them. They can then 
present particles of these scaffolds as antigens to T cells and elicit immune responses to the 
materials. 
In chapter 3, we have speculated that the increased infiltration of M1 phenotype 
BMMФ into the 60 mg/ml scaffold is due to the expression of MMPs and proteolytic 
enzymes that degrade the electrospun matrix, facilitating the migration of BMMФ into the 
scaffold. A degradation study of PDO (60 mg/ml and 140 mg/ml) must be done to confirm 
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this hypothesis. A quantification of the secreted MMPs and enzymes should also be done to 
identify the particular factors released by MФs that degrade electrospun matrices.  
 This study also needs to be extended to electrospun scaffolds created by polymers 
other than PDO. This model of fiber/pore-size modulating MФ phenotype needs to be 
validated by scaffolds of other polymers. Also, these studies have been performed in 
BMMФ, which are typically considered to be relatively immature. It needs to be 
investigated whether these phenotypic switches can be induced in more mature MФs such 
as peritoneal MФs. Also, the differences in genetic background of mice and its influence on 
the phenotype of BMMФ also needs to be explored. We have observed that BMMФ from 
C57BL/6, B6x129 and Balb/c mice induce varying levels of Arg1 and iNOS expression in 
BMMФ. It is known that C57BL/6 mice are pro-Th1 whereas Balb/c and 129 are pro-Th2. It 
has been reported that the outcome of myocardial infarct healing in mice strongly depends 
upon the genetic background. It was shown in the study that 129 mice display an 
augmented inflammatory response after myocardial infarction compared with other mouse 
strains such as Balb/c or C57BL/6 [205]. It has also been documented that 129 mice have 
high levels of circulating IgE and increased expression of IgE receptor (FcεRI) and greater 
sensitivity to anaphylaxis when compared to C57BL/6 mice [206].  
This dissertation work primarily dealt with the involvement of mast cell and MФ 
involvement in biomaterial healing. The involvement of neutrophils in the process of 
biomaterial healing must also be explored since they are first responders and are capable 
to producing several cytokines and growth factors such as TNF-α, IL-1β, IL-8, MIP-1α and 
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VEGF [211]. They could therefore be involved in phenotype modulation of MФs at the 
implant site.  
 A study analyzing the regenerative or wound healing potential of BMMФ also needs 
to be performed. The main focus of this thesis was the potential for angiogenesis. The 
M1/M2 phenotypic responses in relation to scar tissue formation and tissue remodeling 
have not been explored.  
VII.3 Concluding Remarks 
  In conclusion, this study demonstrates that biomaterial architecture can influence 
MФ activation to either M1 (pro-inflammatory) or M2 (anti-inflammatory/tissue 
regenerative). MФ phenotype was studied as a mechanism by which biomaterial 
architectures promoted angiogenesis and healing. Overall, the study demonstrates that 
electrospun PDO scaffolds with large fiber/pore-size induce a M2 phenotype, promote 
angiogenesis and are more efficient at cell recruitment and infiltration in vivo . Majority of 
these recruited cells in vivo are of a M1 phenotype (iNOS positive) in the small fiber/pore-
size scaffold whereas, the large fiber/pore-size scaffold shows a mixed population of iNOS 
positive and negative cells. We have also shown that the PDO scaffold of large fiber/pore-
size also signals differently than the small fiber/pore-size scaffold.  
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